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ABSTRACT 
 
Because of shared physiological, anatomical and metabolical features with 
humans, mice have served for a long time as mammalian disease models. In particular, 
these last ten years have been the golden age for this favoured model animal. Human and 
mouse genome projects show that there is 95% genome homology. Spurred by this fact, 
research attention has shifted from reading these sequences to deciphering the functions 
of these genes. The 1980s saw the remarkable achievement of homologous recombination 
in mammalian cell culture systems. Later in the 1990s, innovative gene trapping 
strategies were developed to enabled random mutagenesis. Today, the goal is to generate 
more versatile tools to avoid limitations posed by these earlier mutagenesis strategies. 
Many public and private research centers have united with the aim of mutating all mouse 
genes. In order to achieve this mutagenesis, the first requirement is a set of practical and 
efficient viral or plasmid based vectors that can be used globally in the genome. This will 
be aided by advances in understanding of biological events such as gene transcription, 
recombination, and embryonic stem cell cycle. In addition, technical improvements such 
as vector development, precise cell culture assay, and recombinant DNA delivery will 
also be important. The vector design work in this PhD thesis encompasses 0.00001 % 
ofthese efforts but may to out to be highly relevant. 
 
The main aim of this PhD project was to construct a versatile FLEx gene trapping 
cassette that efficiently generates precise multipurpose alleles. Multipurpose allele design 
allows genome many types of genomic modifications such as knock-outs, hypomorphic 
alleles, conditional alleles, protein tags and GFP (green fluorescent protein) fusions. 
Multipurpose alleles reduce both the work and cost associated with mutageneis. FLEx is 
a strategy for inversional site-specific recombination. During the early phase of the 
cassette development study, the core region was formed by basic pre-mRNA processing 
elements: a synthetic splice acceptor (84); a synthetic polyadenylation site (55);  
transcription termination signals, CoTC (26,116) and/or MAZ4 (3,36). This core was 
flanked by inversely oriented heterotypic lox site pairs, loxP (53) and lox5171 (53). For 
conditional mutagenesis, the FLEx cassette first needed to be neutrally orientated. 
Following Cre induction, it switches to the mutagenic orientation and acts at the level of 
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RNA processing to terminate transcription downstream of the cassette. This application 
was novel in its use of mammalian RNA polymerase terminators, CoTC and MAZ4. 
 
Refinement of the vector design was required to find optimal combinations of the 
transcription elements. In order to increase efficient pre-mRNA processing, 
polyadenylation and  splicing events, we explored factors including the relative distance 
between elements in the cassette and the role of the DNA between splicing acceptor and 
polyadenylation signals. Several FLEx cassette series containing these elements in a 
various configurations were engineered and tested in the first intronic region of pCAGGs-
EGFP-SV40-Neo. This is a plasmid vector consisting of a strong promoter, a hybrid of 
the CMV early immediate enhancer and the chicken -actin promoter, followed by a -
actin intron driving the enhancer green fluorescent marker fused with the neomycin 
selection marker under the control of te SV40 promoter. This laborious design task gave 
rise to a suitable FLEx gene trapping cassette. We next used our vector design to generate 
a multipurpose allele of mouse Jarid1c, a gene on the X chromosome. For this we 
produced FLEx-blasticidin that included the CoTC transcription termination signal and a 
targeting construct for Jarid1c.  
 
Consideration of RNA processing events and transcription termination allowed us 
to develop a practical gene trapping cassette that can be mutagenic in a global manner. 
Strategic placement of mutant and wild type lox sites into the cassette resulted in high 
Cre recombination capacity. The work here thus outlines an elegant strategy to combine 
two allelic variations, a conditional wild type like and knock-out, in one multi-purpose 
allele. Therefore, the FLEx gene trapping cassette will save research time in 
investigations of processes such as cancer by efficiently creating specific mutations.  
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1. INTRODUCTION 
 
1.1 Current strategies for structural and functional characterization of 
genes during mouse development 
  
1.1.1 Background on genome analysis: The goal of genome projects 
  
The genome of an organism is its total genetic information written in DNA code, 
a universal language. In 1990, the Human Genome Project was conducted as a large 
multidisciplinary project with the ultimate goal of sequencing all human DNA. The 
stunning completion of this project opened Pandora’s box, exposing the raw material that 
encodes a human. Importantly, this work was an initial step towards understanding 
complex human developmental systems and exploring factors engaged in serious diseases 
and disabilities. 
 
Although a function has not been described for the majority of genes, we have a 
lot of numerical information that characterizes the human genome structure. It has been 
reported that the human genome is composed of roughly 3 billion nucleotides 
(International Human Genome Sequencing Consortium 2004). Less than 2% of this 
covers protein-coding regions. According to the International Human Genome 
Consortium (2004), the total number of genes is estimated to be 20.000-25.000. Although 
they have been sequenced and precisely mapped, over 50% are still waiting to be mined 
for functional and expression data. Beside protein coding sequences and regulatory 
elements, the human genome is also composed of regions, previously termed junk DNA, 
that do not code for proteins. These regions make up the vast majority, approximately 
97%, of the human genome (Diagram 1). Even tough no direct functions have been 
assigned to these regions, they may affect chromosome structure and dynamics. It is 
crucial to understand the contribution of non-coding DNA to biological processes such as 
evolution. 
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Determining the functions of individual genes, regulatory sequences and junk 
DNA, as well as profiling their organization and interactions in vivo, is now the primary 
task of biologists. Knowledge of an organism’s genome sequence is therefore a catalyst 
for other approaches to interpret genome function. Such interpretation requires time, 
expertise, and interdisciplinary collaboration. The new field of comparative and 
functional genomics will be the main force in revealing genome function. Genome 
sequencing is not limited to humans. Model organism genome projects promote 
comparative genome analysis as a powerful method to identify genes and other novel 
regulatory factors involved biological processes such as chromosome integration, and 
transcriptional regulation (49,63,65,105). Functional genomics is the study of function 
related aspects of genome, gene transcription, translation factor analysis involved in these 
processes (113). Together, comparative and functional genomics bring deeper insight to 
the human genetic script via gathering information about homologous gene and 
regulatory elements. In the near future, this information will fill gaps in our 
understanding of the molecular mechanisms and pathways responsible for normal 
mammalian development. It will also accelerate the development of strategies for 
diagnosis, treatment, and prevention of genetic diseases and disorders (72). 
 
1.1.2 Background on mouse as a model organism 
 
Genetic mechanisms and cellular pathways are similar across species, including 
humans. Model organisms are often used in experimental systems designed to elucidate 
the fundamental mechanisms of developmental processes that underlying normal and 
pathological conditions. Depending on the specific area of research, yeast, worm, fly 
and/or mouse can be used as a model system to study human genes and to explain critical 
biological functions such as the cell cycle. S.cerevisia, A.thaliana, D.melanogaster, 
C.elegans and Mus musculus (house mouse) are the five organisms selected for the 
Human Genome project (72).  One of them, Mus musculus, has been found to be most 
promising for future studies.  In addition to being small and easy to house, short 
generation time makes the mouse a good model animal. In April 2002 the Whitehead 
Institute released the complete mouse genome data. This sequence was then selected by 
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the Mouse Genome Sequencing Consortium to serve as the reference genome. This 
assembly contained approximately 22.444 mouse genes, 75% of them having a human 
genome counterpart. In summary, the high degree of similarity to human gene sequences, 
and human-like physiological and reproductive features, make the mouse an excellent 
model system. One other great advantage of using mice is that genomic manipulations 
can be used make more sophisticated mouse models. Finally, certain mouse models 
recapitulate human diseases such as lissencephaly, a neurological disorder (52). Thus the 
mouse can serve as a model system for studies of immunology, neurobiology, 
reproduction, cancer, and epigenetics. 
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Diagram1 Numerical illustrations of human genome structure 
(Strachan and Read 1996) 
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1.1.3 Basic tools for functional analysis of the mouse genome 
 
In some cases, we can not determine gene functionality in mammalian systems by 
studying the DNA sequence or comparing sequences from two organisms. Therefore, the 
current challenge in genome projects is to develop reliable and efficient scientific 
approaches and methodologies to investigate gene function in mammalian development. 
 
Mutagenesis is an efficient experimental approach to determine mammalian gene 
function by revealing the physiological consequences of specific gene mutation on the 
model organism. At the beginning, spontaneous mutagenesis based approaches were used 
for explore gene function in the mouse model. However, this was limited by low 
mutagenesis frequency (5x10
-6
/locus). Although different mutation types, from point 
mutations to large chromosomal rearrangements, were produced and caused visible 
phenotypes, gene function could not be investigated in a well-organized, defined manner. 
Following this approach, X ray and chlorambucil approaches were invented to make 
mutants in a more regulated way These two approaches cause a wide range of 
chromosomal rearrangements, however, they affect more than one gene and create 
ambiguity in identification of target gene and its function. This led to the evolution of 
other approaches to design ideal mouse models for elucidating gene function. We can 
classify these classical mutagenesis technologies as: (1) phenotype driven mutagenesis, 
largely achieved by ENU chemical mutagenesis, and (2) genotype driven mutagenesis by 
gene trapping and gene targeting strategies. In addition to these, RNAi technology that 
inhibits gene transcription is promising to illuminate mammalian gene function. 
 
Mutagenesis approaches take different routes to unravel genome functionality and 
each has advantages and disadvantages  (Table 1). 
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Table1 Basic approaches for producing genetic change in the mouse 
 
1.2 Gene trapping through targeting 
 
Since the completion of the mouse genome sequence, one major resource to 
appear has been bacterial artificial chromosome (BACs) libraries. This has now shifted 
the focus of the field to functional genomics. Modification of the mouse genome through 
insertion of mutations is central to this field. The previous section gave general 
information about the principles of widely used mutagenesis approaches, such as ENU 
induced chemical mutagenesis, and considered their strengths and weakness. Among 
these approaches, gene trapping and gene targeting play pivotal roles in creating mouse 
mutations, and are most promising to characterize gene function, structure, and 
expression. 
 
To produce complete loss of function mutations, gene trap mutagenesis involving 
plasmids or viral vectors, has up until now been the technology of choice. In fact, after 
the first release of the mouse genome, gene trapping was the primary strategy to identify 
mouse genes that had not yet been isolated and cloned. Unlike gene trapping, gene 
targeting involves homologous recombination between DNA in the chromosome and 
newly introduced DNA. Depending on vector design, allelic series can be generated. 
Definition Advantages Disadvantages
Phenotype driven chemical 
mutagenesis
Generation of point mutations by
alkylating agent ENU.It creates
mostly partial loss of function and
gain of function allele in germ cells
Generate allelic series of a single
gene                                                
No prior assumption for genes and
pathways                                         
Random mutagenesis-unpredictable 
phenotypes  * Difficult to 
identification of DNA regions 
responsible for desired phenotype
Gene trapping-genotype driven 
mutagenesis
Mutagenesis by random insertion of 
promoterless reporter gene flanked 
by splicing acceptor and polyA signal
Highthroughput for loss of function
studies                                         
Rapid identification of distrupted
gene and less time cost
Random fashion mutations-
unpredictable phenotypes 
Gene targeting-genotype 
driven mutagenesis
Targeted mutagenesis by 
homologous recombination between 
endogeneous DNA sequences and 
newly introduced DNA sequences.
Defined,predictable phenotypes,no
interfering with observation
Requirement-knowledge of targeted
gene structure and expression and
convenient cassette for each allele
*Rare homologous recombination 
RNAi
A process in which double stranded
RNA direct the sequence spesific
degradation of mRNA and
knockdown phemotype
Time costless,complement to other 
genetic studies
Not useful for studying every genes
because of in some physiological
conditions RNAi machinery is not
expressed in some cells and tissues 
Summary of Basic Mutagenesis  Approaches
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Both trapping and targeting technologies can be implemented in cultured mammalian and 
embryonic stem (ES) cells, and  injection of genetically modified mouse ES cells into 
blastocysts can create genetically modified mice. Nevertheless, both technologies have 
some limitations. Gene trapping can only be employ for certain genes expressed in ES 
cells. For genes that are not mutable with the gene trapping approach, gene targeting can 
be a reliable mutagenesis source. Another bottleneck of gene trapping is generating 
mutant mouse lines (97,115). Low rates of germline transmission with trapped ES cell 
lines give rise to the more sophisticated targeted mutagenesis strategy. Unfortunately 
there two notable disadvantages of gene targeting: (1) low targeting frequency in 
mammalian systems compared to other eukaryotic systems such as yeast, and (2) time-
consuming protocols. The latter can be attributed to the need to gather information about 
gene structure and the process of designing a suitable vector for each allele. 
 
The future of functional genomics depends on strategies that employ both 
trapping and targeting. For this aim it is important to generate a novel vector that will be 
applicable to the vast majority of mouse genes. This will enable high-throughput 
generation of mouse mutants.  
 
1.2.1 Gene trap mutagenesis 
 
1.2.1.1 Basic trapping vectors 
 
Enhancer, promoter, and gene trapping vectors are the major vehicles for 
generating random insertional mutagenesis in mouse ES cells. All three kinds of trapping 
vectors can be plasmid or viral based and they can include modifications such as reporter 
genes, e.g., -galactosidase (Table 2), and/or a selection drug resistance marker such as 
neomycine (Table 3). 
 
An enhancer trap vector is composed of a reporter gene under the control of a 
minimal promoter and a selectable marker, generally an antibiotic resistance gene 
suitable for mammalian systems (Figure 1). The expression of the reporter gene in ES 
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cells is dependent on integration of the enhancer vector into a region near cis-acting 
regulatory elements that promote reporter gene expression. Because of this, enhancer trap 
mutagenesis is not feasible to identify transcriptionally inactive genome regions in mouse 
ES cells. Another impediment to this approach is the difficulty of identifying and 
isolating a gene by trapping its enhancer, a transcription regulatory region. In complex 
organisms, enhancers are located at certain distances from the related gene and have the 
ability to communicate with promoters from this distance. This phenomenon has been 
shown in the regulation of the homeotic Abdominal B gene (Abd-B) in Drosophila (92). 
Based on this distance model, one of the other limiting factors for enhancer trapping 
mutagenesis is failure to identify gene by cloning efforts at the vector integration site. 
Enhcancer traping, nevertheless, has a high trapping frequency and is not limited to only 
genes that are expressed in undifferentiated ES cells (50). Enhancer traps are especially 
useful for mapping and identifying transcription regulatory elements (17), despite being 
less efficient for mutagenesis (119). 
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Table 2 Common reporter molecules 
A reporter molecule is an easily assayed fluorescent or enzyme based protein encoded by 
a reporter gene. Among the enzyme based reporter molecules Beta () galactosidase is 
the useful one in mouse ES cell systems. It is highly stable and easy to detect by X-gal 
staining due to its enzymatic activity. It also has a fusion form, -geok (-galactosidase-
neomycin phosphotransferase encoded by the fusion gene lacZ-neomycin phospho 
transferase. Recently green fluorescent protein (GFP) from jellyfish and its mutant 
variants have been introduced into mammalian cells and transgenic animals. GFP and its 
variants, such as red fluorescent protein, can be visualized in living cells as well as in 
early mouse embryos. 
 
 
 
 
 
 
Table 3 Common selectable markers 
Selectable markers are reporter protein molecules encoded by antibiotic resistant genes. 
Because of the low toxicity to mammalian cells and efficient selection features, neomycin 
is the most commonly used for selection purposes. The minimum requirements for 
promoters that drive expression of selectable genes are that they should be active in the 
target cells and that they have no regulatory effect on selectable marker and endogenous 
gene Expression. But some hybrid promoters like CAGGs (CMV immediate early 
enhancer fused) have a position effect depending on the genome site of vector 
integration.  
 15
  
 
                        
                    
Figure 1 p3LSN enhancer trap vector in action 
Enhancer trap vector p3LSN is composed of the hsp68 minimal promoter, lacZ as a 
reporter marker, and neomycin driven by HSVtk promoter as a selection marker. When 
the vector randomly integrates into a target gene, X, -galactosidase and neomycin are 
expressed. This trapping leads to an incomplete null mutation (Stanford and Cordes 
2001). 
 
Promoter trapping vectors were generated to circumvent enhancer vector 
limitations for gene isolation and mutagenesis efficiency. The general structure of a 
promoter trapping vector includes a promoterless reporter gene and a selectable marker 
(Figure 2). Reporter gene expression in this approach depends on insertion of the vector 
into an exon to generate a fusion transcript of the targeted exonic sequences and the 
reporter gene. This approach is highly mutagenic, producing loss of function mutations in 
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ES cells. However, it is restricted to genes that are transcriptionally active in ES cells. It 
has also very low trapping frequency (34,47,119).  
 
 
 
Figure 2 p-gal promoter trap vector in action 
When the promoter trap vector integrates to the coding sequence of the target gene, X, a 
fusion protein consisting of upstream endogenous exonic sequence and neomycin is 
produced. Compared to enhancer trapping, the promoter trapping mutagenesis rate is 
high, although this is dependent on the strength of polyadenylation element (pA) which 
truncates the trapped transcript downstream of pA (Stanford and Cordes 2001). 
 
Gene trapping is the most widely used mutagenesis system in ES cells. Two types 
of vectors can be used depending on the aim: intron and exon trapping vectors. They are 
characterized by a promoterless reporter gene flanked by a splice acceptor (sA) and a 
polyadenylation signal (pA). An IRES (Internal Ribosomal Entry Sequence) can also be 
used in gene trapping vectors for bicistronic mRNA production (Figure 3). A reliable 
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splice acceptor site (sA) splices to the donor splice site (sD) of the trapped gene, captures 
the RNA and a pA signal then truncates the transcript. However this depends on the 
strength of splice acceptor and polyadenylation signal (114). In cases where the sA is 
weak, the gene trapping vector can be excised, failing to knock-out the gene. 
 
 
 
  
Figure 3 pIRES-geo gene trap vector in action 
pIRES-geo gene trap vector is composed of RNA processing elements. When it 
integrates to the intron region of target gene, X, it creates a mutation at the RNA 
transcription level. The sA and pA signals play are critical for the mutagenesis success 
rate. If the sA signal is weak, splicing machinery will skip the vector and it leads to 
vector removal. The pA signal should be also strong to prevent downstream gene 
expression. In the end a fusion protein is produced (Stanford and Cordes, 2001). 
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Today many public and privately funded efforts are turned towards 
revolutionizing vectors for efficient gene trapping (NIH Planning Meeting for a 
Knockout Mouse Project 2005). The improvement of vector design will be one of the 
critical factors for high throughput insertional mutagenesis in ES cells as discussed in the 
following chapters.  
 
1.2.2 Gene targeting mutagenesis 
 
1.2.2.1 Targeting vectors 
 
A targeting vector includes: exogenous DNA containing basic elements; 
sequences homologous to the desired chromosomal integration site; a selectable marker; 
a reporter gene; and a plasmid backbone. The structural features of the exogenous DNA 
must be considered to generate the desired mutation at the target region, a high rate of 
homologous recombination, and efficient identification of recombinant clones. Targeting 
vectors can be classified as either replacement vectors or insertion vectors.  
 
1.2.2.1.1 Replacement vectors 
 
  Basically, a replacement vector is composed of: a 5 to more than 10 kb homology 
arm for efficient double reciprocal recombination between the vector and endogenous 
target site; a dominant positive selection marker serving two aims: (i) generation of 
mutation on exons and/or regulatory sequences of the endogenous target gene,  (ii) 
identification of recombinant cells; a negative selection marker to eliminate various 
subpopulations that have retained the negative selection marker through the random 
integration of the vector (Table 3); a linearization site outside of the homology arm; and 
the plasmid DNA backbone. Target chromosomal sequences are replaced by vector 
sequences after a double crossing event involving the flanking homologous region 
(Figure 4). 
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Figure 4 Gene targeting with a replacement vector 
In this figure, grey boxes illustrate exon regions of a target gene and crosses show the 
homologous recombination between the vector and endogenous gene. Following the 
correct homologous recombination event, the two critical exons of the gene are replaced 
by the neomycin gene of the linearized replacement vector. In some events, the marker 
gene only interrupts the exon, instead of replacing it, creating a frame-shift mutation. 
 
1.2.2.1.2 Insertion vectors 
 
Insertion vectors have the same structural features as replacement vectors. The 
major difference between them is the linearization site of the insertion vectors on the 
homology arm. Unlike replacement vectors, insertion vectors undergo single reciprocal 
recombination (Figure 5). 
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Figure 5 Gene targeting with an insertion vector 
The vector linearization site on the homology arm is shown by green double lines. The 
single reciprocal recombination generates a duplication of the target gene exons, making 
the insertion vector highly mutagenic. 
 
1.2.2.2 Recombinant alleles generated by replacement and insertion 
vectors 
 
The first awesome example of mutant allele generation through homologous 
recombination was the disruption of hprt via insertion of a selectable marker, neomycin 
into its exonic region (16). Targeted modification of the beta globin locus was done in the 
same way (93). At that time, every attempt at gene targeting aimed to generate a 
complete loss of function mutation, namely a knock-out allele. Today the generation of 
null mutants is also the most common gene targeting strategy. Replacement vectors are 
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preferred for this strategy. Depending on vector design and targeting strategy, mutations 
can be generated that yield hypomorphic (partial loss of function), or hypermorphic (gain 
of function) alleles. 
 
1.2.3  Major topics for effective targeted trapping strategy 
 
1.2.3.1 Plasmid vector design 
 
The development of complex and more versatile plasmid based vectors has been 
expanded in parallel to the exponential increases in mouse genome information, BAC 
resources (especially the C57/B6 mouse strain and some 129 substrain genomic DNA 
libraries), and the unraveling of mammalian biological phenomena such as transcription 
termination. 
 
Today, both basic trapping and targeting vectors have been revised to generate 
genetic changes in the genome that vary from single nucleotide mutations to large-scale 
chromosomal rearrangements. Advanced vector designs combining trapping and 
targeting vectors have extended their structural elements to handle critical biological 
processes, e.g transcriptional control.  One application for this new recombinant 
technology is site-directed mutagenesis, a major agenda for many mouse mutagenesis 
consortiums. Recombineering technology in prokaryotic (E.coli) and mammalian systems 
has made pivotal contributions towards achieving any desired mutation in mouse 
genome. 
 
1.2.3.2 Contributions to plasmid vector design and construction 
 
1.2.3.2.1 Recombineering technology in E.coli 
 
Vector construct assembly is the first step for an effective targeted trapping 
strategy. Routinely this process consists of screening a genomic library to obtain the gene 
of interest, followed by restriction mapping and numerous cloning and subcloning steps. 
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From the desk to the bench, this process seems to be laborious, highly time consuming 
and very expensive. In addition to this, standard recombination techniques are not 
feasible for manipulation of large segments. Large constructs are not stable in some 
cloning vectors. Technology taking advantage of homologous recombination in E.coli, 
allows one to bypass time-intensive, inconvenient cloning steps for vector construction 
(28).       
 
This strategy has been referred to as recombineering (20), recombination cloning 
that utilizes E.coli strains to enhance recombination between short DNA homology 
regions, 40-50 bp. Early experimental approaches using the Rac encoded RecET system 
were invented in our laboratory. The basis of this system is to mediate recombination 
between short terminal homology stretches (42bp) of PCR derived ds linear DNA 
fragments and recipient circular plasmid (123). Following successful RecET experiments, 
it was shown that  phage mediated recombination events are more efficient than RecET 
(66). Based on this data, the RecET/Red recombination system was developed in our 
laboratory. The system components RecE and Red are 5I – 3I exonucleases, and RecT 
and Red are DNA annealing proteins (66,69). The last member, Red, serves as a 
protection factor of unstable linear DNA via inactivation of endogenous E.coli host 
exonuclease RecBCD (Figure 6). 
 
The Red ET recombineering system has been applied to alter various kinds of 
DNA targets including E.coli chromosomes, high copy number plasmids, and BACs.  
Today the majority of laboratories use this technology to avoid laborious steps such as 
cloning and subcloning of large DNA molecules (BACs)  and to generate 40 kb deletions 
or insertions (Figure 7).  
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Figure 6 Red-ET recombination mechanism 
Red-ET recombination utilizes homologous recombination to repair the double strand 
break. In E.coli, following the double strand break triggered by an endonuclease, RecE or 
Red produces two protruding 3I single-stranded ends (here only one is shown). Single 
strand binding proteins then bind to single strand DNA. In the strand invasion reaction, 3
I
 
single stranded ends find the homologous region of a second chromosome and make a 
synapsis. In the single strand invasion reaction, the single-strand DNA binding protein 
and DNA complex bind to the complementary protein-DNA complex. 
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Figure 7 Contributions of Red ET recombination to DNA engineering 
Recombination based DNA engineering has a wide variety of applications. The first  
application (left side) is the subcloning of a DNA sequence from a donor DNA molecule 
(mostly BAC DNAs for targeting vector generation because it is the primary genomic 
DNA library source).The linear DNA is PCR amplified plasmid DNA backbone in which 
the target region from the donor DNA source is  subcloned  without the PCR requirement 
that prevents the PCR sourced mutagenesis. The pink lines represent the homology arms. 
The middle and right figure illustrates the PCR amplified DNA molecules. The middle 
mechanism leads to selection marker insertion into target DNA. Through this mechanism 
subtle mutations (right figure) and site directed mutagenesis target sites (e.g loxP) can be 
inserted. 
 
1.2.3.2.2 Recombineering technology in mammalian system 
 
During the last decade, the development of new genetic tools revolutionized our 
ability to manipulate mouse ES cells and mice. Earlier reverse genetics studies centered 
on making complete knock-out mutants. Unfortunately, this research had some critical 
limitations. First, gene targeting in ES cells requires the use of a selection marker such as 
neomycin. This marker gene is generally under the control of a strong promoter in ES 
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cells. However, there is a strong possibility that this promoter will interfere with the 
endogenous target gene promoter, causing complex phenotypes that are unspecific to the 
target gene. Second, many genes are developmentally important in mouse. The complete 
inactivation of a gene can be lethal at early embryonic or post-natal development, 
preventing the study of its function at later stages in development or in the adult. In order 
to circumvent these limitations, site-specific recombination systems were developed and 
added into classical plasmid vectors to allow more sophisticated perturbations to the 
mouse genome. 
 
20 years ago, engineering the mouse genome through classical gene targeting was 
a great challenge in molecular biology. But, the refinement of genome engineering using 
site-specific recombination tools revolutionized this area. Reverse genetics redefined this 
revolution. From creating small changes, such as deletions and subtle mutations, to large-
scale chromosome rearrangements, site-specific recombination is a widely applicable tool 
in mouse genome engineering.  
 
Cre-lox from the bacteriophage P1 and Flp-Frt from the budding yeast 
Saccharomyces cerevisia are two basic elements of the site-specific recombination tool. 
Both Cre and Flp are two members of  integrase superfamily. They share a common 
DNA recombination mechanism that involves strand cleavage, exchange and ligation at 
such high fidelity that recombination occurs without any gain or loss of nucleotides and 
without the need for a cofactor. In the case of Cre recombinase, it has been suggested that 
the energy required to drive the recombination reaction is derived from the recombinase 
protein itself. 
 
Despite their mechanistic similarity, Cre and Flp show diversity in terms of DNA 
recognition sites and temperature-activity. Cre and Flp target sites are composed of 13 bp 
palindromic sequences, inverted repeats separated by 8 bp asymmetric core sequences, 
spacers (Figure 8). In addition to the basic target sites loxP for Cre and FRT for FLP, 
alternative recombinase recognition sites were discovered. 
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5
I
 ATAACTTCGTATAATGTATGCTATACGAAGTTAT  3
I 
 
 
 
3
I
TATTGAAGCATATTACATACG ATATGCTTCAATA 5
I 
 
 
 
5
I
 GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC 3
I
 
 
 
3
I
CTTCAAGGATAAGAGATCTTTCATATCCTTGAAG 5
I 
 
Figure 8 Recombination target sites: loxP for Cre and FRT for Flp 
The figure shows Cre recombinase target sites, loxP (on top figure), and Flp recombinase 
target sites, Flp (below). The spacer sequences marked as red nucleotides are illustrated 
by black arrows on top and grey arrows below. The triangle represents the asymmetry of 
the spacer for Cre on top, the circle represents the asymmetry of the spacer for Flp. The 
inverted repeats flank the spacer on both sides.  
 
The recombination reaction involves two highly coordinated strand cleavage and 
exchange steps. Based on crystallography studies, the integrase family members are 
known to act as tetrameric complexes. In the first step, two recombinase monomers bind 
to the inverted sequences on each side of the spacer and create tetrameric complexes 
together with another two monomers bound to the second recombination target sides. 
Two opposite recombinases catalyze the first breakage of phosphodiester bond on one 
strand in the spacer region. Tyrosine 324 residues of both recombinase molecules then 
make a nucleophilic attack on the DNA backbone, and a specific covalent bond is  
constructed between the tyrosine and a phosphate entity that is termed a 3
I
-
phosphotyrosine bond. This leads to free 5
I 
OH formation and they attack the partner 
strand on the other target site to form a Hollyday junction. Before the second strand 
breakage, the two cleaved strands religate. Then the other reverse recombinase monomers 
use the same mechanism to promote the second strand cleavage. Following the second 
two-strand exchange, the final recombination product is released (Figure 9). The relative 
orientation of these target sites with respect to each other on a DNA segment determines 
the recombination type including sequence excision, duplication, integration, inversion 
and chromosomal translocation (Figure 10).   
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Figure 9 Site-specific recombination mechanism 
 A) Formation of the tetrameric complex of four recombinase monomers bound to 13bp      
inverted repeats flanking the 8bp spacer. 
 B) First step is the breakage of the phosphodiester bond in the spacer region by opposite 
recombinase monomers. Following this nucleophilic attack, a 3
I 
phosphotyrosine bond is 
formed. 5
I
 OH is then released and attacks the partner strand on the opposite side, thus 
generating an intermediate holiday junction. The two cleaved strands then religate. 
 C, D) In the second step, the other recombinase monomer couple undergoes the 
nucleophilic attack, promoting a similar reaction on the second strand DNA. 
 E) Completion of strand exchange and release of recombination product. 
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Figure 10 Recombination reactions mediated by Cre of Flp (Dymecki 2004) 
 The relative orientation of target sites with respect to one another determines the 
recombination types.  
A) Excision of DNA segment between the two head to tail positioned recombinase 
target sites. Products are linear DNA molecule and circular molecule possessing 
target sites. The reverse reaction is the integration of this circular molecule into 
the linear molecule. 
B) Inversion of DNA segment between two target sites arranged in head to head 
configuration. 
C) Exchange sequences distal to target sites presented on two linear molecules. 
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Cre and Flp have different temperature sensitivities. As for their activity at 37
0
C, Flp 
is weakl compared to Cre. Cre was shown to be active over a wider range of temperatures 
than Flp, with maximal performance at 42, making it advantageous for use in vivo. To 
improve the activity of Flp, a mutant variant Flpe (enhanced Flp) was developed by 
introducing four amino acid changes (14). Flpe has activity equivalent to that of Cre in 
ES cell cultures. 
 
Combining the Flp and Cre system with homologous recombination will allow  an 
investigator to target cells that would be otherwise inaccessible. The critical 
considerations of high technology vector design combined with site-specific 
recombination systems and use genome engineering will be detailed in section 2.3.4. 
 
1.2.3.3 The schemes of vector design for generation of null alleles 
 
  Null mutation is a mutation that leads to a complete loss of function of both 
alleles (autosomal genes and X chromosome-linked genes in females), or a single allele 
(X chromosome- and Y chromosome-linked genes in males) of the target gene. Basic 
strategies that can be employed to generate loss-of-function mutations include: (1) 
deletion of the entire target gene or important gene region, such as the promoter or 
translation start codon (ATG) by replacement with selectable marker genes, such as lacZ 
or GFP, or a target gene (cDNA) homologue under the control of cis-acting regulatory 
elements; and (2) interruption of the coding exon via insertion of a drug resistance 
marker. Two main types of vectors can be used for these aims in mammalian cells, 
namely replacement and insertion vectors. 
 
Deletion of an entire target gene by introducing a drug resistance or reporter gene 
with the replacement vector is a perfect strategy to creation complete null mutations. 
However this strategy is not applicable to the majority of mouse genes because of their 
size. Replacement type vectors can be applied to generate deletions from several kb up to 
20 kb (62,64).  The deletion of the entire16 kb mouse Dspp gene, which is responsible for 
dentin mineralization, with the lacZ-neo-tk targeting construct is strong evidence that this 
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kind of knock-out strategy results in phenotypes without secondary unspecific effects 
(96). 
 
Deletions encompassing the promoter of a target gene may inhibit gene 
expression at the level of RNA transcription. For example, a 2.5 kb deletion in the 
promoter region of the amyloid precursor-like gene, APLP1, using a PGK-neo-UMS 
targeting cassette, totally eliminated APLP1 expression (64). This strategy requires strict 
preliminary study of the promoter and other regulatory elements of the target gene (42).   
 
Another critical point for knock-out allele generation is the selection of exon sites. 
Null alleles can be created in most cases by introducing a selectable marker into the 5
I
 
exons rather than exons encoding the C terminus of a protein (41). For example, targeting 
the mouse ND gene (a neurological disease gene, Norrie) in the second exon containing 
the ATG translational codon with a neo-HSvTK targeting vector totally ablated the gene 
(8). However, not every experimental design based on insertion of a selection marker into 
the critical exon region of a target gene will create straightforward knock-outs. There are 
some critical pitfalls that prevent this approach from applying to every gene. One of them 
is that the mutant exon carrying the selection marker may not be recognized by splicing 
machinery and skipped. This results in transcripts initiated from the endogenous promoter 
that may delete the mutant exon or even additional exons from the mRNA. Deletion of 
the mutant exon or a group of exons with a unit number of codons may result in low 
levels of protein production. For example, during glutamate transporter gene (GLT1) 
targeting, the detection of transcript from the mutant GLT1 allele attributed to the lack of 
exon 4 from the mutant allele (99). In addition to this phenomenon, the excision of the 
mutant exon or exon groups in some conditions results in modified protein production, 
mostly because of aberrant splicing. This can be illustrated by the following example. 
Targeted interruption of exon 8 of the mouse L1 gene, which is responsible for normal 
nervous system development, by neo-tk plasmid led to a 190 kb mutant isoform of the 
wild type L1 adhesion molecule in the mutant mouse brain due to exon 8 skipping (22). 
 
 The possible neighborhood phenotypic effect in generation of knock-out alleles 
can be explained by selection cassette interference. Many researchers have shown that the 
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introduction of a PGK-neo cassette into the target locus causes unpredictable, complex 
phenotypes, far from simple knock out phenotypes. The targeted inactivation of the 
mouse myogenic regulatory gene MRF4 carried out by three independent groups is one 
example of this kind of effect. Three different alleles of MRF4 were generated by Olson, 
Arnold and Wold by deleting different coding sequences with a PGK-neo cassette that 
varied in transcription direction. These alleles showed different phenotypes, from 
lethality, the worst case, to viability. Transcription of the cassette in the same direction as 
neighbor gene Myf5, another myogenic factor located around 8 kb downstream of MRF4, 
interfered with Myf5 expression and subsequently decrease its expression (78). This 
could be explained by the position effect of the PGK promoter as well as the removal of 
regulatory elements governing the expression of genes within a close proximity. This 
mostly applies to gene clusters. Thus in addition to avoidance of strong promoter usage, 
such as PGK in a vector design, strict considerations of the gene structure and 
organization within the genome, as well as the regulatory element location, cannot be 
ignored when creating knock-outs.  
 
Insertion vectors, although rarely used for gene targeting, can also be used to 
generate knock-out alleles. Like replacement vector design, creation of an insertion 
vector includes some components that promote high-throughput mutation. The basic 
design steps for insertional vectors are: (1) construction of a homology region to the 
target locus which has unique linearization site, (2) placement of the exon of the targeting 
gene on the homology region, and (3) positioning a selectable marker into the plasmid 
backbone or homologous region.  It should be noted that the recombinant allele is 
characterized by the duplication of the homologous arm and the exon of the endogeneous 
gene following total vector integration. One very critical point for vector design is to 
consider possible unintended recombinant alleles generated after vector insertion by a 
single reciprocal recombination. In most alleles, exon duplications are highly mutagenic. 
But this depends on some factors. If the duplicated exon does not create a frame shift 
mutation, the protein will be functional.  In order to ensure that the exon duplication was 
highly mutagenic, stop codons can be introduced into the single exon in the targeting 
vector. Like in the case of replacement vector null mutations, internal exon mutations 
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rather than 5’ exons generate incomplete knockouts because the N terminal protein is left 
partially or totally functional. 
 
Gene targeting with a conventional replacement vector has two limits. In addition 
to being a low-throughput process compared to random mutagenesis, it requires 
construction of unique targeting vectors for each new allele. In order to circumvent this 
limitation and to increase the efficiency of targeted knock-out generation and 
chromosomal deletions, two 129/Sv (129S5/Sv/Ev/Brd) libraries genomic libraries were 
built (124). Any clones isolated from these libraries are essentially ready to use vectors 
composed of genetic elements for gene targeting: a drug resistance gene; the 5
I
 or 3
I
 
portion of mini hprt gene; a site directed mutagenesis tool; a lox site for chromosome 
engineering; and a coat-color tag for stock maintenance of mutant mice. 
 
Newly developed insertion vectors, namely 5
I
 and 3
I
 Hprt insertional vectors 
(MICER vectors), carrying sequences homologous to the target, integrate into the specific 
target region. The recombinant allele generated by this vector is recognized as the 
duplicated target region separated by vector backbone. This can make them more 
mutagenic than replacement vectors. The plasmid backbone of MICER vectors has a 
splicing acceptor to affect splicing machinery and prevent mutant target region splicing. 
This is advantageous compared to the conventional replacement vector. In addition to 
their probable higher mutagenecity frequency, MICER vectors have a higher targeting 
frequency than conventional replacement vectors. These vectors destroy both alleles of a 
target gene because of different drug resistance markers in trans. They are 
multifunctional, creating both knock-out alleles and subtle mutations such as deletions 
and duplications. All these properties make MICER a convenient option to classical 
replacement vectors (Figure 11). 
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Figure 11 Gene targeting with 3
I
 insertional vector (MICER) 
Illustration of gene targeting with a 3
I
 hprt insertional vector which is composed of a coat 
tagging minigene A (agouti), a lox site flanked hprt exon3-9 fragment and a puromycin 
resistant gene positioned in the vector backbone. The homologous arm of the vector is 
composed of single unique enzyme for vector linearization and a homolog sites including 
exon3 and 4 from the target gene. When the vector undergoes single reciprocal 
recombination, it leads to duplication of homology arm including exon3 and 4 of the 
endogenous gene. Exon4 spliced into duplicated exon3 creates a frame-shift mutation that 
terminates RNA transcription. 
 
An important factor affecting correct gene targeting frequency in mammalian 
systems is the length of homology to the targeted locus and homology rate. As a result of 
this, the last consideration for both replacement and insertion vectors design strategies 
should be construction of the homology arms. The longer the homologous arms, the 
higher the targeting efficiency, is the key rule for successful homologous recombination 
in ES cells and mammalian cell types. Therefore, homology arms for both replacement 
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and insertion vectors should be at least 5, but optimally more than 10 kb, and derived 
from the same genomic DNA origin (isogenic DNA). 
 
1.2.3.4 Vector design schemes to generate alleles carrying subtle 
mutations 
 
Simple inactivation of a gene only allows the analysis of a null phenotype. 
However a series of changes at the nucleotide level of either a coding or a non-coding 
regulatory region can be more informative about gene function. These subtle mutations 
include gain of function and knock-down mutations. Two basic strategies can be applied 
to generate subtle mutations,  “hit and run”, and “double replacement” strategies. 
 
1.2.3.4.1 Hit and run 
 
Insertion type vectors are generally used in this strategy. In this strategy, a 
mutation is introduced in two steps. The first step is homologous recombination using an 
insertion vector to generate a duplication at the target locus carrying the small mutation 
and to integrate a positive and negative selection marker. Following this homologous 
recombination, spontaneous intrachromosomal recombination between the duplicated 
genomic sequences excises the selection markers along with one complement of the 
duplication from the target locus (Figure 12). 
 
Intrachromosomal recombination depends on the length and degree of homology 
between the duplicates (68). This event can be stimulated by incorporating a rare cutting 
endonuclease site, most likely 1Scel, into the plasmid backbone. The first example of this 
hit and run strategy was the insertion of a subtle mutation carried in the second exon of 
the Hox2.6 locus (40). 
 
1.2.3.4.2 Double replacement   
 
Replacement vectors are used in this strategy. Like the hit and run strategy, the 
double replacement strategy depends on two rounds of homologous recombination. In the 
first round, a positive and negative selectable marker is introduced into the target region. 
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The second homologous recombination requires gene targeting, unlike the hit and run 
approach, to introduce a subtle mutation by another replacement vector carrying the 
mutation. This strategy introduces several mutations simulataneously into the target locus 
in only one round of recombination (Figure 13). 
 
Compared to the hit and run strategy, the replacement strategy is very useful in 
studies of gene structure and functionality. Deletion is generated in the very first step and 
mutations can then be made that individually or in combination target the functional 
domains of the gene. Briefly, this strategy offers an opportunity to introduce a series of 
deletions or point mutations into regions of a gene that are responsible for regulating 
expression. So far this approach has been applied to the ColA1gene (109). 
 
Figure 12 Hit and run strategy 
The first step is the insertion of vector to the target region via single reciprocal 
recombination that leads to duplication of 5
I
and 3
I
 endogenous gene regions. The second 
step includes intrachromosomal recombination or uneven sister chromosome exchange. 
This leads to the excision of plasmid sequences, selection markers (neomycin as a 
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positive, HSVTk as a negative selection marker) and one complement of the duplication 
region from the target locus 
 
 
 
Figure 13 Double replacement strategy 
The first step is the deletion of the target region by replacing it with selction markers, 
neomycin for positive selection and NS HSVTk for negative selection. The second 
replacement targeting vector carrying the subtle mutation (yellow star) then undergoes 
homologous recombination and the mutation is inserted into the target region. 
 
1.2.3.5 Expanding the frame for allele generations: High technology 
vectors meet SSR tools 
 
A wide variety of sophisticated and versatile gene trapping and targeting vectors 
tmodified to contain site directed recombination tools generate innovative alleles to 
introduced desired mutations into the germ line. The most popular application of these 
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vectors is the generation of specific mutations. This strategy requires a selection marker 
in the targeting vector that is then excised along with the all or a part of the endogenous 
gene . Basic replacement vectors carrying a positive selectable marker flanked by either 
loxP or FRT target sites are mostly used for this strategy. For this kind of vector 
construction, orientation of the site-specific recombinase target sites is critical. Deletions 
will occur in the interval of DNA between two direct repeats. In the presence of Cre or 
Flp, the selectable marker cassette is removed. This elegant and time saving strategy 
prevents position effect of a selection cassette under a strong promoter, thereby 
circumventing genetic ambiguity arising form changes in neighboring gene expression. 
 
Classically, gene targeting involved in generating null mutations by introducing a 
selectable marker to the target gene or an essential part of this gene. Deletions of 5
I
 
coding regions are a convenient way to create a nonfunctional gene. To the same extent 
as the deletion sites of endogenous gene, the size of the deletion plays pivotal role in the 
generation of a complete null mutation. Ideally, complete non-functional mutation 
requires larger deletions. Nonetheless, the size of the target gene or fragment that can be 
removed is limited by size when using a classical replacement. Coupled with site-directed 
mutagenesis tools, more than 30 kb deletions can be created in the mouse genome using 
classical gene targeting. 
 
Critical points for vectors that combine site-directed mutagenesis tools with 
classical trapping and targeting vectors include: the relative position of recombinase sites 
and marker genes; the placement of floxed or flrted gene markers; and whether, following 
recombination, the loxP or FRT sites will be left to use for future genetic manipulations. 
To create conditional null mutants, it is essential to position recombinase target sites 
around the entire gene. Nevertheless, this is only possible for monoexogenic or short 
genes. Alternatively, an essential part of the target gene can be selected for the 
construction of recombinase target sites. The target sites should be positioned in a manner 
to generate total mutation upon the recombinase exposure. A suitable position of the 
target sites should be selected that does not compromise functionality of endogenous 
gene or its neighbors, yet keeps the conditional allele fully functional for recombination.  
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The mechanism of target site recognition and recombination stimulation emplyed 
by recombinase enzymes has a profound effect on the location of target sites. In 
biological systems, some of proteins locate their target sites very rapidly, the likely result 
of diffusional collusions between the protein and DNA molecule. Such mechanisms 
generally involve the initial binding at a random DNA site via non-specific, sequence-
independent interactions, followed by intramolecular translocation to the specific binding 
site. This seems simple if one ignores the fact that the protein searches megabases of non-
target DNA. Hence, recombinases that rely on random collision activity can be affected 
by the distance to their target sites. Moreover, previous studies that used Cre mediated 
deletions in somatic cells have pointed out this fact (125). Although, deletions up to 60 
cM have been achieved in ES cells in vitro, Torres and Kuhn reported that this frequency 
decreased from 70% over a distance of 4kb to 2% over a distance of 10kb. In summary, 
the position of a second recombinase target site should be within 10 kb of the selection 
marker (Figure 14). 
  
Further modifications of the vector can be made to expand the application of the 
site directed mutagenesis strategies. Introducing subtle mutations and swapping the 
endogenous sequences for exogenous ones are other applications of these kinds of 
vectors. General replacement vector configuration serve as a guide for vector 
construction, with the following exceptions: the small mutation should be included on the 
homology arm and floxed or flrted; and, a selectable marker should be directed into a 
large intron or into a region downstream of the pA to avoid putative interference of the 
single recombination target site following recombinase induction. It is critical to 
distinguish the wild-type allele and recombinant allele by incorporating a unique 
restriction enzyme into the small mutation site (Figure 15). 
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Figure 14 Gene deletion along with the marker removal through site directed 
mutagenesis 
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Figure 15 Introduction of a subtle mutation along with marker removal 
The figure shows gene targeting with a replacement vector containing a subtle mutation 
in one of the endogenous exons and two lox sites in opposite orientation. Following the 
insertion of the mutation, Cre recombinase is induced and this removes the positive 
selection marker, neomycin. 
 
Another vector configuration enables the creation of knock-in alleles. Although 
the vector configuration pattern is the same previous ones, the design approach includes 
the incorporation of exogeneous sequence into the selection marker gene (Figure 16). 
This generates heterology in one homology arm of the vectors, but as some studies have 
shown,  this heterogenecity does not affect homologous recombination. 
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Figure 16 Sequence swapping along with exon replacement and marker removal 
Gene targeting with a replacement vector that includes an exogenous sequence as a 
heterogeneous site in the left homology arm (green rectangle), and a positive marker 
flanked by two lox sites positioned in opposite orientations. Insertion of the exogenous 
sequence via homologous recombination is followed by site directed recombination and 
removal of the positive selection marker neomycin. 
 
Alternative to wild type, the usage of mutant site directed target sites make 
creation of more functional and elaborate allele designs possible. For example, the 
placement of two pairs of heterotypic mutant lox sites, lox51 and lox71, around the 
essential part of a target gene creates inversion not excision (Figure 17). The flexibility 
obtained by combining two site directed mutagenesis systems, Cre and Flp was an 
innovative step to generate multifunctional alleles. 
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Figure 17 Inversion 
The inversion reaction between two mutated loxP sites, lox 51 and lox 71 (stars). 
Following Cre exposure, the DNA fragment between the mutant lox sites is inverted  and 
a double mutant lox is generated which cannot be recognized by Cre recombinase. 
 
1.2.3.6 Multipurpose Allele Strategy - Cornerstone of the targeted 
trapping approach 
 
Gene trapping has liberated scientists from laborious genetic screens and 
biochemical approaches to identify new genes and molecules involved in highly complex 
biological events in mammalian systems. Gene trapping provides a powerful and rapid 
approach for simultaneously mutating and identifying genes. Scientific groups in major 
American and European centers have made remarkable progress in generating ES cell 
libraries by making large-scale knock-outs of mouse genes using the gene trapping 
approach. In accordance with the International Gene Trapping Consortium declaration in 
2006, gene trapping efforts have resulted in approximately 60% of mouse genes being 
trapped and the public availability of ES cells. Though gene trapping can be termed a 
high throughput, large-scale mutagenesis method, it has limitations detailed in section 2. 
On the other hand, the alternative approach, a direct strategy based on homologous 
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recombination, has some remarkable pitfalls related to recombination frequency in 
mammalian systems. 
 
Incorporation of gene trapping-like cassettes and site-specific mutagenesis tools 
into these basic vectors was a powerful invention to both create mutations and identify 
new mouse genes. Instead of generating different allelic variation one-by-one, these 
innovative vectors allow multiple allelic variations to be created simultaneously. Also, it 
circumvents embryonic lethality and permits the dissection of mammalian gene function 
and regulation at all developmental stages and in adulthood. 
 
1.2.3.6.1 Multipurpose strategy to create knock-out alleles 
  
This strategy relies on the knock-out first approach in combination with 
conditional applications. An advanced replacement vector is used for this multifunctional 
allele creation. This vector incorporates gene trapping cassette that consists of efficient 
RNA processing signals (sA and pA), a promoterless reporter gene (lacZ, GFP or RFP), 
and a positive selection marker such as a drug resistance gene (neomycine or 
hygromycine). This cassette is flanked by a site directed mutagenesis tool, the Cre-lox 
system. As an alternative to the Cre-lox system, the Flpe/FRT system can be utilized for 
conditional knock-out strategies in ES cells with the same efficiency (14). 
 
The principle of this approach is like the random gene trapping approach, the 
vector inserts in frame into an intron region of a mouse gene and traps the upstream exon 
regions of endogenous gene. One critical consideration for vector design is the RNA 
processing signal strength. One of the pitfalls is poor splicing of the gene trap cassette 
because of a weak sA signal. An efficient pA signal in this vector truncates the transcript 
so that endogenous gene is not transcribed into mRNA downstream of the cassette site. 
Because the reporter gene is driven under the endogenous gene promoter, this vector 
reports the promoter function of endogenous gene. Under some conditions, IRES also can 
be inserted into the trap cassette to produce bicistronic mRNA. An important 
consideration for vector design is that when there is significant distance between the lox 
sites, the efficiency of Cre recombinase is diminished. Therefore lox sites should be 
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placed as close possible to each other in the vector. The homology arm of this chimeric 
vector for efficient recombination should be at least 5-8 kb or optimally 10kb in each 
arm. 
 
A successful lacZ reporter gene trap style cassette for a multipurpose knock-out 
first allele was constructed in our laboratory and used to generate a multifunctional Mll2 
allele. The strategy to generate the knock-out Mll2 allele was based on inserting a gene 
trapping cassette in an intron of Mll2, producing a knock-out at the RNA processing 
level. In the transcribed pre-mRNA, exon 1 is spliced to the cassette instead of exon 2 
because the strong sA, engrailed 2, in the cassette captures the RNA transcript (35). The 
cassette consists of IRES (48), reporter gene lacZ, and the selection marker neomycin 
(34). It permits the expression of this fusion protein driven by the Mll2 promoter.  The 
strong pA, SV40 pA, in the cassette truncates the transcript so that the gene can not be 
transcribed into mRNA downstream of the cassette site. This gene trapping style cassette 
is flanked by FRT regions that allow Flp to excise the cassette from the intronic region of 
Mll2 to generate a conditional allele. By introducing another site directed mutagenesis 
site to the second exon of the gene, this exon can be removed and a frame shift mutation 
generated by the splicing of exon 1 to exon 3. This frame shifted mRNA includes some 
stop codons. This converts the conditional Mll2 allele to a constitutive null (Figure 18). 
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Figure 18 Knock-out first multipurpose allele strategy 
The Mll2 multipurpose knock-out allele vector is generated by a gene trap cassette that 
includes: a splicing acceptor, IRES, a lacZ-neomycin fusion gene, -geo, a stop codon 
and a SV40 pA signal that are flanked by FRT on both sides; loxP sites; and a 
homologous arm for MLL2 target region. The second loxP site within the homology arm 
of the vector is inserted into exon 2 as part the selection marker cassette flanked by two 
loxP sites positioned opposite orientation, that allow removal of the selection marker via 
Cre induction through Red-ET recombination. The cassette in the first intronic region of 
the Mll2 gene generates a Mll2 null allele by trapping and truncation of the  endogenous 
mRNA. Only lacZ-neo is expressed. Flp mediated recombination leads to cassette 
removal and the Mll2 gene is expressed again. The Mll2 conditional allele is converted 
into knock-out allele via Cre mediated recombination. The deletion of exon 2 creates a 
frame-shift mutation. Splicing of exon 1 to exon 3 generates a stop codon that truncates 
the mRNA. 
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1.2.3.6.2 Multipurpose strategy to create conditional alleles 
 
Conditional mutagenesis relies on either deletion of an early frame-shifting exon  
or deletion of  entire gene if it is small. This can be accomplished by placement of two 
loxp or FRT sites on either side of an essential section of a gene or entire a gene. 
Nevertheless, this is impractical unless the gene is very small and/or the exon is frame-
shifting (62,64). Thus a gene trapping style lacZ-neo cassette for the knock-out first 
multipurpose allele strategy cannot be applied for many mouse genes. The design of each 
conditional allele requires careful consideration of gene structure. In this PhD study, 
another gene trapping style cassette called “generic FLEx” was created that does not need 
to consider individual gene architecture. 
 
  FLEx is a strategy for inversional site pecific recombination with Cre. General 
inversional site-specific strategies are enhanced by the placement of mutant lox sites, 
lox66 and lox71, or wild type loxp and mutant lox5171 on either side of a DNA fragment 
in a tail to tail configuration.  The resulting recombination inverts the intervening 
sequence (Figure 19). 
 
Starting with this stunning strategy, a generic FLEx gene trap style cassette was 
built. The fundamental elements of this cassette are: a splicing acceptor; a 
polyadenylation signal; and a selection marker. In a novel application, here, transcription 
termination signals were included in this cassette. This cassette is flanked by loxp and 
lox5171 in either side, positioned tail to tail for inversional site specific recombination. 
The basic approach for generic conditional mutagenesis with this cassette is its placement 
into an early intron. In one orientation, this cassette should be neutral so that it is not 
recognized by splicing machinery. Following Cre exposure, the cassette should turn to 
the mutagenic orientation which captures the splicing of the transcript and then 
terminates it, thereby preventing mRNA production.  
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Figure 19 FLEx Strategy  
The figure shows a vector cassette combined with a site specific mutagenesis tool. Two 
pairs of heterotypic lox sites, loxP and lox5171 are positioned in an inverted figuration on 
each side of the cassette. Upon Cre induction, two homotypic sites, either loxP 
(represented by blue) or lox5171 (represented by green), are recombined. The cassette 
inversion leads to uni-direction lox sites that produce a deletion. 
 
1.2.3.6.2.1 The Jarid1c Multipurpose Allele 
 
The application of the targeted trap approach with the FLEx cassette to the X-
linked mouse gene Jarid1c is the second critical aim of this project. The strategy to 
generate a conditional Jarid1c allele is based on inserting a neutrally oriented FLEx 
cassette into an early intron. In the transcribed pre-mRNA, exon1 is spliced to exon 2 
instead of the cassette. Because the splicing machinery cannot recognized the cassette, it 
skips the oppositely oriented, meaningless, sA and instead recognizes the endogenous sA. 
Following Cre recombination, a null Jarid1c allele is created. This time the endogenous 
transcript is trapped by a synthetic splice acceptor. (synt sA). The synthetic 
polyadenylation signal (synt pA) truncates the trapped transcript (55). Because it is not as 
strong as other polyadenylation signals, such as SV40 pA, the strong transcription 
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termination signal CoTC ensures that Jarid1c is not expressed from the downstream 
region of the cassette. The selectable marker blasticidin is driven by the SV40 promoter. 
In the mutagenic orientation, this promoter is excised by Cre recombination to prevent 
interference with endogenous and neighboring gene expression that could create an 
unexpected phenotype (Figure 20). 
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Figure 20 Conditional first multipurpose allele strategy 
The conditional allele of Jarid1c. The vector is a FLEx cassette that contains: a synthetic 
splicing acceptor, the blasticidin (BSD) gene under control of both the bacterial promoter 
EM7 and the mammalian promoter SV40, the strong transcription termination site CoTC, 
heterotypic lox sites flank the cassette, and 10 kb left and right homologous arms for 
Jarid1c excluding its promoter. In the conditional state of the gene, the neutrally oriented 
FLEx cassette inserts into the first intronic region of the gene and does not interfere with 
splicing of endogeneous Jarid1c. Exon1 splices to exon 2. By Cre mediated 
recombination, the cassette inverts into the mutagenic orientation. Splicing machinery 
skips the endogeneous splice acceptor, exon 1 is then spliced into the cassette instead of 
exon 2. This prevents Jarid1c gene expression downstream of pA and the transcription 
termination sites. Transcription termination site CoTC is novelly used inthe trapping style 
targeting studies. It successfully prevents gene transcription playing a regulatory role in 
RNApol II dependent transcription termination (detailed in section 3.1)   
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1.2.3.7 Ideal ES cell and isogenic genomic DNA sources 
 
ES cell lines are cultures of pluripotent, unspecialized cells derived from epiblast 
tissue of the inner cell mass of an early stage embryo called a blastocyst. Studies 
conducted in the mid-1980s showed that these lines are valuable vehicles to enable 
targeted mutagenesis. Although, homologous recombination frequencies in mouse ES 
cells are higher in part because of their shortened cell cycle, gene targeting strategies 
remain low rate and low throughput. As of 2005, nearly 3600 mouse genes were mutated 
with  this targeting strategy. This covers only less than15 % of the mouse genome (94). 
 
Although numerous factors influence homologous recombination frequency, the 
problems largely stem from the use of targeting vectors and ES cells with different 
genetic backgrounds. ES cells from the 129 mouse strain were the first to be derived and 
have become more widely used. Nevertheless, significant genetic variation exists among 
the different substrains. Before learning of this diversity, the first generation of gene 
targeting vectors were constructed  from  129/SvJ DNA for use in 129/Sv ES  cells. The 
sequence diversity between vector DNA from 129/SvJ and genomic DNA of 129/Sv ES 
cells may have reduced targeting efficiency and made targeting impossible.  Some 
experiments targeting Tyr in Chr 7 reflected this problem (41).  Now, the only alternative 
to the 129 ES cell strain is C57/Bl6. However, its robustness for mutagenesis has not yet 
been demonstrated. This means that 129 ES cell are still the only tool for mutagenesis 
studies, and efforts should now be directed to extract more information from genomes of 
129 substrains and expand low cost 129 substrain BAC libraries. 
  
1.3 Transcription termination in mammals 
 
Without any known exceptions, all living cells carry their hereditary information 
in DNA. DNA is transcribed into RNA, and this RNA code is translated to produce 
proteins, depending on a cell’s need. In mammals, in addition to the tight control over 
transcription elongation, transcription termination also has complex regulation. 
Transcription termination is the process that first releases the transcription complex and 
then RNA polymerase from the template DNA. A critical reason for building the FLEx 
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cassette in this project is the need to reduce nonproductive transcription and prevent 
transcriptional interference at downstream genes, processes that are both linked to 
polyadenylation. It was found that both of these processes depend on the same DNA 
sequences placed 3’ end of the eukaryotic protein coding genes. Some studies indicate 
that polyadenlylation factors and mRNA cleavage processes are involved in transcription 
termination (121). Cleavage-polyadenylation signals are the cis elements required for 
normal termination in mammals. This was the good evidence of the relationship between 
two these processes. 
 
Two general models, the anti-terminator model and the torpedo model, 
hypothesize how transcription termination and cleavage-polyadenylation affect each 
other. Although, they show mechanistical differences in lower and higher eukaryotes, the 
basics are the same in both organisms.  Recently a hybrid model, the anti-terminator-
torpedo model of RNAi , explained some of the paradoxes of anti-terminator and torpedo 
models (6). 
  
 For the anti-terminator model, the presence of poly(A) signals at the mRNA 3
I
 
end, 10-30nucleotides upstream of the cleavage site, initiates conformational changes in 
the factors associated with elongation (Figure 21). 
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                                                                                        Buratowski 2005 
 
Figure 21 Anti-terminator model 
Transcription termination is caused by conformational changes of the RNA pol II 
complex. The presence of a polyadenylation signal leads to the dissociation of nascent 
RNA from the template DNA, either with the release of anti-terminator factors and/or 
termination factors. CTD phosphorylation shows a changeable pattern in every stage.  
 
 
As for the torpedo model, which has the same logic of bacterial rho dependent 
transcription termination, cleavage of the transcript at the polyadenylation site generates a 
new 5
I
 end that is rapidly degraded by a 5
I
 -3
I
 exonuclease. This nuclease enzyme 
somehow enhances RNA polymerase II elongation complex destabilization results in 
termination (Figure 22). 
 
Compared to lower eukaryotes like yeast, some mammalian genes have two 
cleavage sites to ensure efficient transcription. 
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Figure 22 The torpedo model 
Cleavage of the transcript by endonuclease at the polyadenylation region generates a 5’ 
unprotected end. This is the target site for a 5
I
 -3
I
 exonuclease, Rat1 for yeast, Xrn2 for 
mammals. Via exonuclease activity, degradation of RNA downstream of the cleavage 
sites triggers RNA pol II dissociation, resulting in termination.  
 
1.3.1 The presence of a CoTC element in some mammalian genes makes 
transcription termination through the torpedo model more powerful 
and efficient 
 
RNA processing signals are critical for the transcription termination. 
Nevertheless, some studies have shown that there are more specific sites positioned 
downstream of  the poly(A) that contribute to this process (26,116). 
 
In mammals, some genes, such as human -globin, have a CoTC site several 
hundred nucleotides downstream of the polyadenylation signal. These sequences are 
required for auto-cleavage of nascent RNA transcript at this site. The 5
I
 end generated by 
the CoTC cleavage acts as a second entry point for the 5
I
 -3
I
 mammalian exonuclease 
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Xrn2. This exonuclease then passes along the RNA, reaches the 3
I
 RNA region and 
finishes the degradation. This action destabilizes the polymerase complex and dissociates 
it. 
 
1.3.2 Pausing of the polymerase by G-rich sites, MAZ4 
 
In addition to cleavage process contribution to transcription termination, some 
researchers have shown that pausing of the polymerase downstream of the 
polyadenylation site encourages transcription termination. Pausing can be triggered by 
particular DNA/RNA sequences or sequence specific DNA binding proteins that act as a 
roadblock to RNA polymerase II movement.  
 
It has been demonstrated that pausing is critical for transcriptional termination of 
some yeast and mammalian genes. In Schizosaccharomyces pombe, pause sites adjacent 
to the pA in ura 4 and 200bp downstream of pA in nmt2 genes are required for 
transcription termination (S.pombe pause sites).  The human 2 globin gene and C2 
complement, as well as mouse immunoglobulin genes, display downstream elements that 
serve as pausing factors. Pausing downstream of the pA site is an integral part of  the 
torpedo model of termination. Transcription complexes are slowed by pausing sites and 
exonuclease activity catches up them to release the template. 
 
The presence of G rich specific sequences positioned downstream of the strong 
pA signal in human C2 complement was shown to be the binding site for the zinc finger 
protein, MAZ, a transcriptional regulation protein (3). It was thought that the four MAZ 
protein binding sites arranged in tandem promoted termination of human C2 complement. 
Moreover, it activated polyadenylation. MAZ4 element mediation of transcription 
termination is dependent on proximity to a strong pA. RNAi-mediated depletion of MAZ 
protein indicated that there is no effect of the MAZ4 region on pausing activity. 
Therefore other factors or the specific G rich sequences, either at DNA or RNA level, 
may act to promote Pol II pausing. Although the mechanism of action of G rich pausing 
elements is not known yet, it might be explained by conformational change of a loop in 
the G rich sequences after the transcription complex and RNA polymerase II enzyme is 
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released from the template. On the other hand, the proximal distance of this region to the 
pA may act to retain RNA polymerase II  in close proximity to the poly(A) site. When 
cleavage takes place, Pol II may then be close enough to be affected by Xrn2, 5
I
-3
I
 
exonuclease that is also involved in pause-dependent transcriptional termination (36). 
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2. RESULTS 
 
2.1 Generic FLEx gene trapping cassette and its operation principle 
 
In the present study, we planned a multipurpose conditional-first, knockout strategy 
that is applicable to the majority of mouse genes regardless of their complex structure. 
Our starting consideration was that the majority of mammalian genes have relatively 
large intronic regions compared to the exons. The strategy was thus focused on inserting 
a cassette into an early, ideally first, intronic region of the target mouse gene in such as 
way that it did not interfere with downstream transcript production unless Cre 
recombinase was used to mediate a unidirectional cassette inversion. The construction of 
a versatile FLEx gene trapping cassette was the first aim of my PhD project.  During the 
early phase of the cassette development study, the basic pre-mRNA processing elements, 
synt sA (84), synt pA (55), and transcription termination signals, CoTC (26,116) and/or 
MAZ4 (3,36), formed the core region of the cassette flanked by inversely oriented 
heterotypic lox site pairs, loxP (53) and lox5171 (53). Then, the selectable marker was 
inserted between the synthetic sA and pA (Figure 23).  
 
 
 
 
Figure 23 Architecture of generic FLEx gene trapping cassette for multi-purpose allele 
strategy              
  
The FLEx cassette for conditional mutagenesis first needed to be neutral in one 
orientation, and following the Cre induction, mutagenic at the level of RNA processing 
by terminating transcription downstream of the cassette insertion. In this manner, this 
project is exploratory in using mammalian RNA polymerase terminators, CoTC and 
MAZ4, as neither of them has been applied in such a way before. 
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Considering the complexity of transcriptional control mechanisms in mammalian 
systems, understanding the individual functions of the cassette elements and their 
collaborative contributions to mutagenesis was the initial focus of my work. I wanted to 
explore two questions: What is the most effective distance between each element in the 
cassette? and, What effect does the character of the DNA between the splice acceptor and 
poly(A) signals have on efficient pre-mRNA processing events, splicing and 
polyadenylation? Therefore a series of FLEx cassettes containing elements in various 
configurations was engineered and tested in the first intronic region of pCAGGs-EGFP-
SV40-Neo, a plasmid vector consisting of a strong promoter that is a hybrid of the CMV 
early immediate enhancer and a chicken -actin promoter followed by a -actin intron 
driving an enhancer green fluorescent marker fused to a neomycin selection marker under 
the control of the SV40 promoter. The cloning strategies used to assemble the first series 
of FLEx cassettes are detailed along with the results in figures 24, 25, 26 and 27. 
 
Figure 24, section A, summarizes the PCR cloning strategy of the lox regions 
from 4.3 kb pBLF5171 into the NotI(670) and KpnI(772) cloning sites of 2.9 kb 
pBluescriptKS(+/-). The BsIWI restriction enzyme recognition site is CGTACG, and it 
generates a 5
I
 overhang (GTAC). The KpnI restriction enzyme recognizes GGTACC and 
it generates a 3
I
 overhang (GTAC). In this cloning strategy, the DNA fragments cleaved 
by these two enzymes were ligated. The colonies were selected by ampicillin (100 
μg/ml). When the candidate recombinant plasmids were analysed with the SacI enzyme, 
recombinant plasmids, C4 andC5, were distinguished by their large size band compared 
to non-recombinant plasmids, C1-C3 and C6-C7 (Figure 24B).  
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   Figure 24 Subcloning of the lox regions to pBluescript KS(+/-)    
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After sequencing confirmed that the modified pBluescript KS(+/-) carried lox p 
and lox 5171 sites, synthetic sA, pA, and the transcription termination signal CoTC were 
inserted by PCR cloning between the SnaBI(835) and EcoRI(840)  restriction sites of this 
plasmid (Figure 25). For this study, the pUC18/human -globin gene (3538 bp), kindly 
provided by Prof. Proudfoot, was the source of the CoTC fragment. The CoTC fragment 
of human -globin lays between the genomic region coordinations 64567-64938 on 
chromosome 11. A 3.1 kb fragment of human -globin gene, which spans the genomic 
region coordinates 62179-65316 on chromosome 11, was inserted into the HindIII 
cloning site of pUC18 (2686 bp) (2,25).  
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Figure 25 (A) Subcloning strategy of the pre-mRNA processing elements, synt sA, pA 
and transcription termination signal, CoTC.   
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Figure 25 (B) Verification of pFLEx-CoTC  
Following the modification of 3.191 kb pBluescript KS(+/-) through PCR cloning of sA, 
pA  and CoTC, the 3.661kb recombinant plasmid was named pFLEx-COTC. pFLEx-
CoTC was analysed by several restriction endonuclease enzymes (listed on gel). 482bp 
CoTC PCR product was used as a control.  
 
The third subcloning step was to engineer the FLEx gene trapping cassette to 
contain two RNA pol II termination signals. The 150 bp MAZ4 RNA pol II pausing 
signal was inserted into the KpnI(1314) and EcoRI(1316) cloning sites of the pFLEx-
CoTC (Figure 26 A). pMLP III, kindly provided by Prof. Proudfoot, was used as a 
source of MAZ4 pausing region from the human complement genes C2 and factor B 
(116). In this plasmid, the wild type 4 G nucleotides repeat sequences site, MAZ4, was 
placed into the region downstream of the synt pA (Figure 26 A). pMLPIII was 
constructed by the insertion of the pUC19 polylinker to the pAdML (Stratagene).  MAZ4 
was inserted into the KpnI and EcoRI cloning sites of the pMLP III. Then, synt pA was 
cloned between the BamHI and KpnI sites of pMLP III (116). 
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Figure 26 Modification of  FLEx-CoTC construct via cloning of MAZ4 
(A) Strategy of vector construction. 
(B) 2% agarose gel electrophoresis of the KpnI/EcorI digestion of FLEx-CoTC-MAZ 
plasmid, 150kb. The sequencing facility verified correct modification of pFLEx-CoTC. 
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In order to determine the extent that the MAZ signal in the FLEx gene trapping 
cassette contributes to transcription termination, the CoTC site was removed from the 3.8 
kb pFLEx-CoTC-MAZ4. First, the plasmid was digested with the double enzyme system, 
AatII and Asp718, an isoschizomer KpnI. Asp718 generated a blunt end product, so the 
AatII site was blunt ended by 3
I
 overhang removal and fill-in of 3
I
 recess using Klenow 
(DNA pol I), and the plasmid was then re-ligated (Figure 27).  
 
 
    Figure 27 Construction of pFLEx-MAZ4  
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2.1.1 Evidence for communication between pre-mRNA processing 
factors, splicing, and polyadenylation 
 
The first series of FLEx cassettes constructed with synthetic sA, synthetic pA and 
different configurations of the transcription termination signals CoTC and MAZ4, was 
cloned into the -actin intron region of the pCAGGs-EGFP-SV40-Neo in a bidirectional 
fashion. This was done to generate neutrality in one direction and a knock-out, at the 
level of GFP transcriptional control, in the other (Figure 28).  
 
 
 
Figure 28 Bi-directional cloning of the FLEx cassette and its two different sets 
Cloning strategy for the FLEx cassette composed of synthetic sA, pA, and transcription 
termination signals CoTC and MAZ4 to the unique SgrA1 site in the -actin region of 
pCAGGs-EGFP-neo. (2) and (3) illustrate different configurations of the FLEx cassette in 
terms of termination signal usage. In one set, only CoTC was used as a terminator, in the 
other, MAZ4 was used. FLEx cassettes and its two different series were inserted into the 
intronic region in both directions; CAGGs promoter direction and CAGGs anti-promoter 
direction.  
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Figure 29 Insertion of the FLEx cassette into the -actin intronic region of pCAGGs-
EGFP-neo 
 
SgrAI fragments of pFLEx-CoTC-MAZ4 and its two variations were cloned into the 
SgrAI cloning site of the -actin intronic region of pCAGGs-EGFP-neo (upper figure). 
0.7% agarose electrophoresis of SgrAI fragments of the FLEx constructs and pCAGGs-
EGFP-neo is shown (lower figure). 
 
6 different FLEx-EGFP-neo plasmids were generated with this cloning strategy. 
These included FLEx cassettes composed of the two RNA pol II termination signals 
(CoTC and MAZ4) and two variations constructed with either MAZ4 or CoTC inserted 
into the intronic region of pCAGGs-EGFP-neo in two directions, the CAGGs promoter 
direction and the anti-CAGGs promoter direction. Plasmids with the CAGGs promoter 
orientated FLEx gene trapping cassettse were called “mutagenic oriented pFLEx-EGFP-
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neo”. Plasmids with anti-CAGGs promoter oriented FLEx cassettes were called “neutral 
oriented rev-FLEx-EGFP-neo”. In the presence of CoTC and MAZ4, 6.8 kb pFLEx-
EGFP-neo and rev-FLEx-EGFP-neo constructs were built and verified by restriction 
enzyme analysis and sequencing. 
  
The restriction patterns of the mutagenic oriented FLEx-EGFP-neo construct with 
CoTC and MAZ4 are: EcoRI, 546 and 6283 bp; NotI, 3383 and 3446 bp; EcoRI and NotI 
double digestion, 546, 772, 2128 and 3383 bp; BamHI, 1230 and 5599 bp; EcoRI and 
BamHI double digestion, 653 and 6176 bp; SnaBI, 1109 and 5720 bp; and, EcoRI and 
SnabI double digestion, 546, 634, 1109 and 4540 bp (Figure 30). The restriction patterns 
of the neutral oriented FLEx-EGFP-neo construct with CoTC and MAZ4 are: BamHI, 
546 and 6283 bp; SgrAI, 929 and 5900 bp; EcoRI and SnaBI double digestion, 561, 
638, 1090 and 4540 bp; SrfI and SpeI linearized 6829 bp; and, EcoRI and NotI, 
772,1199,1475 and 3383 bp (Figure 31).  
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Figure 30 Map and agarose gel electrophoresis of several digests of pFLEx-EGFP-neo 
before ES cell transfection  
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Figure 31 Map and agarose gel electrophoresis of several digests of rev-FLEx-EGFP-neo 
before ES cell transfection  
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The restriction patterns of the mutagenic oriented FLEx-EGFP-neo construct with 
a single CoTC are: BamHI, 1077 and 5599 bp; SgrAI, 776 and 5900 bp; EcoRI and 
SnaBI double digest, 481, 546, 1109 and 4540 bp; EcoRI and NotI double digestion, 
546, 772, 1975 and 3383 bp; and, SrfI and SpeI both linearized, 6676 bp plasmid 
(Figure 32, left gel). The restriction patterns of the neutral oriented FLEx-EGFP-neo 
construct with CoTC are: BamHI, 577 and 6099 bp; SgrAI, 776 and 5900 bp; EcoRI 
and SnaBI double digestion, 485, 561, 1090, and 4540 bp; EcoRI and NotI double 
digestion, 772, 1046, 1475, and 3383 bp; and, SrfI and SpeI both linearized, 6676 bp 
(Figure 32, right gel). 
 
The restriction patterns of the mutagenic oriented FLEx-EGFP-neo construct with 
MAZ4 are: BamHI, 855 and 5599 bp; SgrAI, 557 and 5897 bp; EcoRI and SnaBI 
double digestion, 259, 546, 1109 and 4540 bp; and, EcoRI and NotI double digestion, 
546, 772, 1753 and 3383 bp (Figure 33, left gel). The restriction patterns for the neutral 
orientation of this construct are: BamHI, 577 and 5877 bp; SgrAI 557 and 5897 bp; 
EcoRI and SnaBI double digestion, 263, 761, 1090 and 4540 bp; and, EcoRI and NotI 
double digestion, 772, 824, 1475 and 3383 bp. SrfI and SpeI linearized both constructs to 
gave a 6454 bp fragment.    
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Figure 32 Verification of mutagenic and neutral oriented FLEx-EGFP-neo constructs 
that include the RNA pol II termination signal CoTC by analysis with several restriction 
endonucleases. 
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Figure 33 Verification of mutagenic and neutral oriented FLEx-EGFP-neo constructs 
containing the RNA pol II pausing signal MAZ4, using restriction endonuclease analysis.  
 
Random mutant mouse E14TG2a cells were established by electroporating the 
FLEx-EGFP-Neo vector series, linearized with SpeI, on the backbone of the pCAGGs-
EGFP-neo. Two weeks following electroporation, and continuous selection of the clones 
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with G418 (0.20mg/ml), the ES clones were examined using a fluorescent microscope. 
Statistical data were obtained from 40 recombinant clones for each construct. The 
fluorescent signals of the cells indicated whether the FLEx cassette randomly integrated 
into the mouse genome in a mutagenic or neutral position. As shown by the positive GFP 
expression the cassette in the neutral orientation was reliable in all vector series (Figure 
34).  
 
 
 Figure 34 GFP assay results of the neutral oriented first series of FLEx-EGFP-neo  
 mouse E14TG2a clones  
                
Fluorescent microscopy analysis of the random stable E14TG2a clones. 3x10 cm plates/ 
40 clones for each transfection were subjected to this assay. Clones expressing GFP were 
classified as 0-15% GFP(+), 15-30%(++), 30-45%(+++), 45-60%(++++) and >60% 
(max). Comparison to the control group (max GFP expression) indicated that all cassette 
configurations did not interfer with downstream GFP transcription.  
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Figure 35 (A) GFP assay results of mutagenic oriented first series of FLEx-EGFP-neo 
mouse E14TG2a clones  
 
Fluorescent microscopy analysis of the random stable E14TG2a clones. 3x10 cm plates/ 
40 clones for each transfection were subjected to this assay. Clones expressing GFP were 
classified as 0-15% GFP(+), 15-30%(++), 30-45%(+++), 45-60%(++++) and >60% 
(max). Compared to the control group (max GFP expression), the GFP assay results held 
by using the clones transfected with mutagenic oriented 3 sets of FLEx cassette indicated 
the cassette in every configuration could not generate mutation at the level of RNA 
processing, GFP was expressed in every condition. 
 
                 
                  
     
Figure 35 (B) In vivo transcriptional activity of mutagenic oriented FLEx –EGFP-neo 
containing both termination signals, CoTC and MAZ4, in mouse E14TG2a clones/10cm 
plate 
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On the other hand, in CAGGs promoter direction, it did not show fidelity for 
mutation leading to a transcription stop at the downstream region of the FLEx cassette, 
EGFP gene  (Figure 35). This could be explained by random integration of the FLEx 
cassette into an active chromatin region of the mouse genome or by inefficient splicing. 
To explore this problem further, some recombinant clones and control clones were picked 
from 96 well plates and expanded into 6 well plates. A RT-PCR assay was performed on 
these clones to determine if the cassette was skipped by the splicing machinery. The 
results showed splicing failure of the cassette in some clones (Figure 36). 
 
 
Table 4 Total RNA concentrations used for RT-PCR assay 
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Figure 36  RT-PCR analysis of GFP expressions in random stables  
(recombinant mouse E14TG2a clones) 
 
(A) In control clones transfected with pCAGGS-EGFP-neo, following the transcription, 
(transcripts were shown as red arrows), the 912 bp - actin intronic region between the - 
actin sD to sA spliced from 1292 bp transcript within the specific RT-PCR primers 
boundaries ; forward primer from the 100 bp downstream of the transcription start site and 
reverse primer from the EGFP region. Thereby, these primers amplified the 380 bp EGFP 
cDNA product (figE, lane 4). If the GFP was not transcribed, the cDNA could not be 
amplified (figE,lane 5). 
(B)  In mutagenic oriented FLEx cassette transfected clones, if the splicing machinery skipped 
the sA in the cassette, and -actin region spliced from the -actin sD to -actin sA. In clones 
transfected with mutagenic  oriented FLEx cassette with both signals, from 2224 bp 
transcript within the RT-PCR primers region, 1844bp was removed (figE, lane 6). In clones 
stable with FLEx –CoTC-EGFP-neo constructs, from the 2067 bp transcript, 1687 bp was 
removed (figE, lane 9). on the other hand for clones stable with FLEx-MAZ4-EGFP-neo, 
1846 bp pre-mRNA produced within the primer borders and 1466 bp region spliced (figE, 
lane 12).For all stable clones, 380 bp cDNA was amplified by RT-PCR primers. 
(C)  If the gene is spliced from the endogeneous donor to cassette splicing acceptor, the 
downstream EGFP can not transcribed and  no  product amplification was seen. RT-PCR 
result for random stable with mutagenic oriented FLEx with both signals (figE lane 7) 
FLEx with CoTC (figE lane 10) and FLEx with MAZ4(fig E lane 13). 
(D) For the neutral oriented FLEx cassette transfected clones, the synthetic sA was not counted 
and the transcript spliced from the enodgeneous donor site to the endogeneous sA site.. 380 
bp cDNA product was amplified by RT-PCR primers (figE, lane 8 RT-PCR result from 
random stable with mutagenic oriented FLEx with both signals, lane 11 FLEx with 
CoTC and lane 14 FLEx with MAZ4)  
 76
 
 
 
 
 
Figure 37(I) First step in the cloning strategy to build FLEx-IRES-RFP-EGFp-neo 
constructs 
First, the upstream SpeI(95) and SrfI(1579) region, covering lox5171, loxP and the 
synthetic sA of the mutagenic oriented FLEx-EGFP-neo construct, was cloned into 
pIRES2-DsRed NheI(591) and SmaI(658) cloning sites.  
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Figure 37(II) Second step in the cloning strategy to build FLEx-IRES-RFP-EGFP-neo 
constructs 
 
Second, the aim was to add IRES-RFP between the synthetic spA and synthetic 
polyadenylation site of the FLEx-EGFP-neo constructs. The 3.1 kb Nde1-filled in NotI 
fragment of the modified pIRES2-DsREd construct was re-cloned to all three mutagenic 
pFLEx-EGFP-neo constructs (containing both CoTC and MAZ4, or only CoTC or 
MAZ4).  
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Figure 38 Neutral oriented FLEx-IRES-RFP-EGFP constructs were engineered through a 
bi-directional cloning approach into pCAGGs-EGFP-neo. The SgrAI cloning site of 
pCAGGs-EGFP-neo was replaced with NheI via Red-ET recombination. All mutagenic 
oriented FLEx-IRES-RFP-EGFP-neo SgrAI sites flanked by mutant and wild-type lox 
regions were changed through Red-ET recombination approach using NheI cloning sites. 
  
We conclude that the splicing and polyadenylation machinery affected each other 
because of the distance between synthetic sA and synthetic pA, and this was the main 
reason for aberrant function of FLEx gene trapping cassette. Because of this, our next 
step was to design a second series of FLEx-EGFP-neo constructs called FLEx-IRES-
RFP-EGFP-neo (Figure 37). This second generation of FLEx cassettes included an in-
frame IRES-RFP sequence to maintain an appropriate distance between the sA and the 
pA. This was confirmed by different restriction enzyme digests and sequencing (Figure 
39-41).  
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The restriction patterns of FLEx-IRES-RFP-EGFP-neo with both transcription 
termination signals are: EcoRI, 546 and 8153 bp; BamHI, 55, 2453 and 6191 bp; and, 
EcoRI and BamHI double digestion, 31, 55, 546, 1876 and 6191 bp. For the neutral 
orientation of the same construct, the restriction patterns are: EcoRI, 2477 and 6222 bp; 
BamHI, 55, 577 and 8067 bp; and, EcoRI and BamHI double digestion, 31, 55, 546, 
1876 and 6191bp (Figure 39). 
 
The restriction patterns of FLEx-IRES-RFP-EGFP-neo containing CoTC are: 
EcorI, 546 and 7999bp; BamHI, 55, 2299 and 6191 bp; and, EcoRI and BamHI double 
digestion, 31, 55, 546,1722, and 6191 bp. For the neutral orientation of the same 
construct, rev-FLEx-IRES-EGFP-neo, the restriction patterns are: EcoRI, 2323 and 6222 
bp; BamHI, 55, 577 and 7692 bp; and, EcoRI and BamHI double digestion, 31, 55, 546, 
1722 and 6191 bp (Figure 40). 
 
The restriction patterns of FLEx-IRES-RFP-EGFP-neo containing MAZ4 are: 
EcorI, 546 and 7778 bp; BamHI, 55, 2078 and 6191 bp; and, EcoRI and BamHI double 
digestion, 31,55, 546, 1501 and 6191 bp. The restriction patterns for the neutral oriented 
FLEx-IRES-RFP-EGFP containing MAZ4 are: EcoRI, 2102 and 6222bp; BamHI, 55, 
577, 7692 bp; and, EcoRI and BamHI double digestion, 31, 55, 546, 1501, and 6191 bp 
(Figure 41).       
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Figure 39 Map and agarose gel electrophoresis of several enzyme analytical digests of 
pFLEx-IRES-RFP-EGFP-neo in both orientations containing two RNA pol II signals, 
CoTC and MAZ4, before ES cell transfection  
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Figure 40 Map and agarose gel electrophoresis of several enzyme analytical digests of 
pFLEx-IRES-RFP-EGFP-neo in both orientations containing a single RNA pol II signal, 
CoTC, before ES cell transfection  
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Figure 41 Map and agarose gel electrophoresis of several analytical digests of pFLEx-
IRES-RFP-EGFP-neo in both orientations containing a single RNA pol II signal, MAZ4, 
before ES cell transfection  
 
All constructs were linearized with SpeI, and E14TG2a cell lines were generated. 
After 14 days, G418 (0.20mg/ml) selection was performed and clones were examined 
under the fluorescent microscope. 40 clones were used for statistical analysis. The GFP 
assay results supported the distance requirement between the sA and poly(A). When the 
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linearized mutagenic oriented FLEx-EGFP-Neo vector integrated into the mouse genome, 
the synt sA and synt poly(A) elements served to respectively trap and truncate the 
transcript. This resulted in EGFP not being transcribed downstream of the cassette 
(Figure 42).  
 
 
 
Figure 42 GFP assay results of mutagenic and neutral oriented second series of FLEx-
EGFP-neo mouse E14TG2a clones 
  
Fluorescent microscopy results for the random stable E14TG2a clones. 3x10 cm plates/ 
40 clones for each transfection were subjected to this assay. Clones expressing GFP were 
classified as 0-15% GFP(+), 15-30%(++), 30-45%(+++), 45-60%(++++) and >60% 
(max). In the presence of both transcription termination signals, compared to MAZ4 
alone (max, 65% of total clones), the CoTC containing cassette was more precise at  
controlling downstream transcription. (+) is equal to 12,5%,and (++) is equal to 20 % of 
total clones expressing GFP. 
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The second generation of the FLEx cassettes was then first tested by transient 
transfection of mouse E14TG2a ES cells. Lipofectamine was used for the vector 
transfection. Compared to stably transfected cells generated by electroporation, the 
mutagenic oriented FLEx cassette was more robust in these transiently transfected cells. 
We observed no trace of the GFP expression in these cells, however RFP was strongly 
expressed as expected. This confirmed the transient transfection of these cells. (Figure 
43). 
 
 
 Figure 43 Transient transfection of mutagenic oriented FLEx-EGFP-neo construct 
Examination of clones in a 6 well plate 24 hours after transient transfection of the vector 
illustrated (scale bar 40X). Under a lens that transmits red fluorescent signals, RFP was 
visualized (left side). However, under a green fluorescent filter, GFP signals were not 
detected (right side). 
 
We also performed a Cre recombination feasibility test on selected clones stable 
for the 3 different versions of the mutagenic oriented FLEx cassette (FLEx-IRES-RFP-
EGFP-neo with both (CoTC+MAZ4) or single transcription termination signal. This was 
done by transiently transfecting the pCAGGs-Cre plasmid, again using the lipofectamine 
approach. We found that the FLEx cassette was robust in terms of Cre mediated 
recombination (Figure 44). 
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Figure 44 Transient transfection of pCAGGs-Cre-puro into the FLEx-CoTC-EGFP-neo 
clone 
Cre efficiency test in a E14TG2a cell clone stable for the mutagenic oriented FLEx-
EGFP-neo construct (scale bar 40X). Control clones were transiently transfected with 
pBluscript KS plasmid. After 24 hours the clone transiently transfected with Cre plasmid 
was positive for GFP expression, while the control was negative. 
 
2.1.1.1 Conclusion 
 
For this kind of applied gene trapping strategy, versatility of the gene trapping 
cassette is very important. With FLEx, our goal was to generate mutations at the RNA 
transcript processing level after inserting the cassette in a sense direction into an early 
intronic region of a target gene. Importantly, we found that the structure of the elements 
comprising the cassette, in addition to their position and proximity to each other, played a 
pivotal role in this mutagenesis. Our efforts during the first and second generation of the 
cassette were directed towards explaining splicing and polyadenylation interference when 
the sites are close together. We were particularly focused on the role of transcription 
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termination signals in preventing downstream gene transcription by RNA pol II. We 
derived two basic conclusions from our experimental efforts; sA and pA elements must 
be separated by a certain distance, and CoTC was more effective then MAZ4 in causing 
transcription termination.  
 
2.1.2 Polyadenylation is required for transcriptional termination but is 
not sufficient 
 
In order to determine the value of the transcription termination signals used in this 
study, the signals were removed from the two differentially oriented FLEx cassettes 
(Figure 45) and random stables were generated by electroporating these two vector 
constructs into mouse E14TG2a cells. Both FLEx-IRES-RFP-EGFP constructs 
containing only sA and pA elements were digested with SpeI, EcoRI and BamHI. The 
restriction patterns of the mutagenic oriented FLEx-IRES-RFP-EGFP construct were: 
EcoRI, 546 and 7629 bp; and, BamHI, 55, 1929 and 6191 bp. The 2453 bp BamHI 
restriction fragment of mutagenic oriented FLEx-IRES-RFP-EGFP containing both 
CoTC and MAZ4 were used as a control. The restriction patterns of the neutral oriented 
FLEx-IRES-RFP-EGFP-neo construct not containing CoTC and MAZ4 were: EcoRI, 
1873 and 6142 bp; and, BamHI, 55, 497 and 7463 bp. The 2477 bp EcoRI fragment of 
the neutral oriented FLEx-IRES-RFP-EGFP-neo construct containing both CoTC and 
MAZ4 was used as a control (Figure 45). 
 
After 14 days, G418 selection (0.20mg/ml) was performed and positive GFP 
expression showed that these signals are required to create a mutation resulting in 
transcription termination (Figure 46). 
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Figure 45 Map and agarose gel electrophoresis of analytical digests of pFLEx-IRES-
RFP-EGFP-neo in both orientations containing no transcription termination signals 
before ES cell transfection 
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Figure 46 GFP assay results of random stables transfected with both orientations of the 
FLEx -EGFP-neo construct containing no pol II termination signals 
 
 
2.1.2.1 Conclusion 
 
Our results demonstrate that because cassettes lacking termination signals could 
not control expression of the relatively small EGFP gene, such a design should not be 
used for mammalian genes, which are more complex in structure and functionality. In 
conclusion, these signals are required for more sophisticated FLEx cassette design.   
 
2.1.3 The best configuration of the FLEx cassette -Blasticidin constructs 
 
There was no doubt about the functionality of pre-mRNA processing signals and 
the termination signal, CoTC, in the mutagenic oriented FLEx cassette. Following 
insertion of the cassette into the -actin intronic region of the CAGGs-EGFP-neo vector, 
truncated EGFP mRNA was produced and high percentages of the random stables 
(E14TG2a clones) were characterized as being neomycine resistant and negative for GFP 
expression. Nevertheless, the reporter gene RFP was not functioning properly in 
recombinant clones. Because we needed a functional mammalian reporter gene to isolate 
recombinant E14TG2a clones among a heterogenic population in a reliable way during 
future gene trapping and targeting experiments, we selected BSD, an antibiotic resistant 
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gene. In neutral oriented second series of FLEx-EGFP-neo constructs, IRES-RFP was 
replaced with BSD under the control the strong hybrid of the SV40 and EM7 promoters 
using the Red-ET approach. All construct maps and restriction endonuclease patterns are 
summarized in figures 47, 48, and 49. 
 
The restriction patterns of mutagenic oriented FLEx-BSD-synthetic pA containing 
both transcription termination signals are: NcoI, 703, 1135, 1518, 1809 and 2000 bp; 
and, KpnI, 641 and 6524 bp. The restriction patterns of neutral oriented FLEx-BDS-synt 
pA are|: NcoI is 281, 693, 825, 1819, 2000 and 2074 bp (Figure 47). The restriction 
patterns of mutagenic oriented FLEx-BSD-synthetic pA containing only CoTC are: NcoI, 
703, 1135,1364, 1809,2000 bp; and, KpnI, 466 and 6545 bp. The restriction patterns of 
the same construct in a anti-sense version ( neutral) are: NcoI, 281, 703, 825, 1809, 1920, 
2000 bp; and, KpnI, 1908 and 5630 bp (Figure 48). The restriction patterns of 
mutagenic oriented FLEx-BSD-SV40 pA containing both CoTC and MAZ4 are: NcoI, 
703, 1135, 1749, 1809, 2000 bp; and, KpnI, 641 and 6755 bp. The restriction patterns of 
neutral oriented FLEx-BSD-SV40 pA with both termination signals are: NcoI, 281, 703, 
825, 1809,2000 and 2305 bp; and, KpnI, 2150 and 5773 bp (Figure 49). For all BSD 
constructs, SpeI has a single site and was used for plasmid linearization before 
electroporation. 
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Figure 47 Map and agarose gel electrophoresis of analytical digests of pFLEx-BSD- synt 
pA -EGFP-neo in both orientations containing both transcription termination signals, 
CoTC and MAZ4, before ES cell transfection  
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Figure 48 Map and agarose gel electrophoresis of analytical digests of pFLEx-BSD-synt 
pA -EGFP-neo in both orientations containing the single transcription termination 
signal,CoTC, before ES cell transfection  
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Figure 49 Map and agarose gel electrophoresis of analytical digests of pFLEx-BSD-
SV40 pA -EGFP-neo in both orientations containing both transcription termination 
signals, CoTC and MAZ4, before ES cell transfection  
 
  
 
 
 
 
 93
In both FLEx cassette configurations, the SV40 promoter could drive BSD 
expression in ES cells. However, one disadvantage of using a strong promoter was its 
interference with both endogenous target gene and neighbouring gene expression. 
Another issue was the possibility that endogenous promoter competition could affect the 
number of clones produced by the recombinant ES cell lines. To prevent this problem, we 
inserted an extra loxP site in front of the SV40 promoter in the neutral oriented FLEx 
cassette. The aim was to use triple loxP recombination following cre induction, and 
remove the promoter in the complete knock-out mutation to prevent it from interfering. 
 
In addition to these configuration changes, we thought to compare a strong pA 
element used in a lacZ expression reporter cassette made by Dr.Guiseppe Testa, with the 
synthetic one that appears in the FLEx gene trapping cassette. Because SV40 pA was bi-
directional, we wanted to explore its contributions to both conditional and complete gene 
inactivation by generating FLEx. E14TG2a stable cell lines containing neutral oriented 
FLEx-EGFP-neo constructs that have either SV40 pA or another synthetic pA were 
generated. The FLEx construct containing only the MAZ4 pausing signal was excluded 
in this performance comparison. 24 hours after the electroporation, 3x10cm plates were 
subjected to G418 (0.20 μg/ml) and 3x10cm plates to BSD (5μg/ml). 14 days later GFP 
expression was assayed. As shown in figure 52, the neutral orientated cassette was 
reliable only in the presence of the synt pA signal. The percentage of GFP positive 
E14TG2a clones was nearly 50% lower with the same cassette in the presence of the synt 
pA  element for G418 selection, and 71.5% lower for BSD selection. Only the random 
stables with neutral oriented FLEx-EGFP-neo containing only the CoTC termination 
signal, gave the same rate of GFP expression as clones subjected to both G418 and BSD 
selection (Figure 50). This demonstrated that in this configuration the cassette functioned 
properly.  Compared to G418 selection, BSD selection gave low numbers of clones. This 
was probably due to CAGGs and SV40 promoter interference.  
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                                                                                                              % GFP 
Figure 50 GFP assay results of neutral oriented third series of FLEx constructs 
transfected into mouse E14TG2a clones.  
 
Fluorescent microscopy of random stable E14TG2a clones. Total clones (n) from each 
3x10 cm plates were examined.        
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Table 5 Stable transfection of pCAGGS-Cre-puro into FLEx-CoTC-BSD-EGFP-neo 
E14TG2a clones 
 
Cre recombination assay results of 6 different clones transfected with neutral oriented 
FLEx-BSD-EGFP-neo construct, half selected by BSD and  the other half by G418 for 14 
days before they were picked. The clones were characterized by total GFP expression 
before the electroporation of pCAGGs-Cre-puro plasmid. 24 hours after transfection, 
each clone was selected for 2 days in puromycin (1μg/ml). After 10 days without any 
selection, the statistics were done. The entire cassette inverted in almost all C3 derived, 
whereas C4 and C5 derived clones showed less efficiency.  
 
In order to test the mutagenic version of the cassette, we performed Cre 
recombination to invert the neutral cassettes and isolated mutagenic FLEx in the 
prokaryotic system, E.coli. Then ES cell lines were electroporated with FLEx-EGFP-neo 
containing either both transcription termination signals or CoTC alone. All clones 
produced by these cell lines were then checked for GFP expression. The cassette in the 
CAGG promoter direction created a strong mutation, completely shutting off GFP 
expression in random stables (Figure 51). In mutagenic oriented constructs, expression 
of the selection marker BSD was under the control of the CAGGs promoter because the 
SV40 promoter was removed following Cre recombination. This prevented SV40 and 
CAGGs competition. Compared to the neutral FLEx-EGFP-neo E14TG2a cell lines, the 
mutagenic FLEx-EGFP-neo cell lines tended to generate a higher percentage of healthy 
recombinant clones in which GFP transcription terminated completely. 
 
C1 55% C4 71%
C2 64% C5 85%
C3 95% C6 60%
Cre recombination efficiency data (percentage of cell show no GFP expression, n = 50)
Clones from BSD selection Clones from G418 selection
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                                                                                                          % GFP 
 
Figure 51 GFP assay results of mutagenic oriented third series of FLEx-EGFP-neo 
mouse E14TG2a clones  
 
To confirm the absence of EGFP expression, proteins were extracted from some 
mutagenic oriented FLEx-BSD-EGFP-neo clones and western blotting was performed. 
Extract from pcDNA6V5-His-SV40-BSD transfected clones was used as a negative 
control and extract from pCAGGs-EGFP-neo empty vector transfected clonse was used 
as a positive control. All the random stables showed no trace of an EGFP specific band 
(Figure 52). 
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Figure 52 No GFP expression was detected in mutagenic oriented FLEx-BSD-CoTC-  
EGFP-neo clones 
 
Protein extracts from random stables (E14Tg2a clones) and two control clones probed 
with a specific mouse polyclonal antibody recognizing the N terminus of recombinant 
GFP protein (EGFP), 29 kDA monomers with 265 a.a. No specific EGFP bands were 
detected in random stables (C1and C2 G418 selected,C3 and C4 BSD selected) and the (-
) control clone transfected with pcDNA6V5-His-SV40-BSD. All extracts were treated 
with goat -actin polyclonal antibody that recognizes the 45kDA protein to demonstrate 
equal amount of proteins were assayed. 
 
2.1.3.1 Conclusion 
 
While constructing FLEx-EGFP-neo containing a BSD marker, we found that a 
unidirectional synt pA element in combination with CoTC, a strong termination signal, 
contributed substantially to cassette mutagenecity as reflected by the loss of the 
downstream EGFP transcription. The anti-sense orientation of these signals did not 
interfere with GFP expression. Recombinant clones, selected by either G418 or BSD 
selection, displayed a stable pattern of GFP expression, showing no variability in the GFP 
expression rate. Also random stables (E14TG2a clones) showed higher levels of cassette 
inversion following Cre induction. Without any doubt, the gene trapping cassette, FLEx 
in this configuration will enable us to achieve our aim of creating a targeted trapping 
strategy that is applicable to the majority of mouse genes. 
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2.2 Multipurpose Jarid1c Allele 
 
In the second part of the project, we aimed to conduct a targeted gene trapping 
strategy using the best variation of the FLEx cassette (section1.5). First, we wanted to 
insert the neutral orientated FLEx cassette into the first intron of a mouse gene to 
establish a multipurpose allele of this gene. To simplify this tactic, the mouse Jarid1c 
gene on the X chromosome was selected (Figure 53) because this gene is in single copy 
in mouse E14Tg2a ES cells derived from 129P2/OlaHsd males. This meant that as 
opposed to autosomal gene targeting, only one-step gene targeting was required for 
Jarid1c. 
 
 
 
Figure 53 General scheme of FLEx cassette insertion into the mouse Jarid1c gene 
 
2.2.1 Construction of conditional targeting Jarid1c vector 
 
From the in-silico mouse genome sequence database (ENSEMBL), the Jarid1c 
gene was identified and mapped. It spans 40.5 kb of genomic sequence on Chromosome 
Xp11.2. It is composed of 26 exons. The annotated BAC clones in ENSEMBL were 
RP23 and RP24 series from the C57/Bl6 strain and CH29-179C2. Because no 129 strain 
BAC clone was listed, targeting vector construction was conducted with the RP23-
147K15 clone. 
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The target intronic region that we aimed to insert the neutral oriented FLEx gene 
trapping cassette into is 3.9 kb. Before starting construction of the conditional allele, it 
was important to map potential Jarid1c transcription regulatory regions of the target site. 
Intron 1 of Jarid1c lays on the X chromosome between the coordinates 147.573.348-
147.578.348 bps. Genomic DNA alignment of the intron I region between these 
coordinates in mouse was done against 6 mammals, Pan troglodytes, Homo sapiens, 
Canis familiaris, Rattus norvegicus, Bos taurus and Macaca mulata. The unconserved 
region between 147.577.072-147.577.167 was selected for cassette insertion (Figure 54). 
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(A) Alignment result of region 147.577.011-147.577.059 
 
             
 
(B) Alignment result of region 147.577.072-147.577.119 
 
 
 
(C) Alignment result of region 147.577.120-147.577.167 
 
 
      Figure 54 Partial alignment profile of intron 1 of Jarid1c 
Part of the intronic region between 147.577.011-059 is conserved between the 6 
mammals shown except Pan troglodytes (Figure A). Although it is not shown, the 
intronic region between 147.574.427-147.577.056 showed this conservation profile 
with some single nucleotide variations. Starting with the region 147.577.056-
147.578.348 in Mus musculus, there was no conservation for the rest of the 6 
mammals (unconserved regions). Figure B and C show part of these unconserved 
regions, and the cassette was inserted between 147.577.119-147.577.120.  
 
  
The cassette was inserted with one-step Red-ET recombination into the 
unconserved region between 147.577.119-147.577.120. 48 bp sequences between 
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147.577.072-119 served as the homology arm portion of the forward PCR primer, and 48 
bp sequences between 147.577.120-167 served as homology arm portion of the reverse 
PCR primer. This region was targeted with PCR product containing the FLEx cassette 
flanked by 48 bp homology arms on each side. After introduction of a pSC101 plasmid 
containing an arabinose inducible Red-ET recombination system into the 147K15 Jarid1c 
BAC containing host, tetracycline (3μg/ml) resistant BAC colonies (DH10B strain) were 
selected. Then, after induction of Red ,, expression, the PCR product was 
electroporated into the BAC colony carrying pSC101 plasmid. Through Red-ET 
recombination, the first intronic region of Jarid1c with neutral oriented FLEx gene 
trapping cassette was modified. Positive colonies were selected with BSD (5μg/ml) and 
CM (15μg/ml). After collecting the candidate recombinant bacterial clones, mini-prep 
plasmid DNA analysis was done with PshA1. This enzyme has 13 sites on the BAC 
backbone and one site in the FLEx cassette. The recombinant 2.6 kb band could be easily 
identified among the non-recombinant colonies (Figure 55).  
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Figure 55 (A) The modification of the wild-type Jarid1c BAC DNA(147K15) 
Insertion of the FLEx cassette to the first intronic region of the Jarid1c BAC (207 kb). 
The coordinates of the 48bp oligonucleotide homology arms A and B correspond to the 
positions of oligonucleotides on Xp11.2. 
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Figure 55 (B) Restriction analysis of Jarid1c BAC DNA after PshAI digestion 
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Figure 55 (B) shows the restriction analysis of recombinant BAC DNA after the 
cassette was inserted into the intron I target region. Recombinant clones were detected by 
PshAI restriction analysis. This enzyme has 13 sites on the BAC DNA backbone, one 
critical position is at 68.7 and the other site was positioned at 71.3 in the FLEx gene 
trapping cassette. The restriction pattern of the recombinant band was 2.6 kb. 
 
The next step after finding the correct recombinant Jarid1c BAC was to generate a 
targeting construct for homologous recombination in a mammalian system, mouse ES 
cells. In order to enhance homologous recombination frequency, because a non-isogenic 
DNA source was used in this project (C57/Bl6), the homology arms of the targeting 
vector were increased. Using a convenient southern blot strategy, we designed the 21.9 
kb targeting vector with homology arms containing 10 kb of the first Jarid 1c exon, 
including the translational start site, (left arm) and 10 kb of exon 2-7 (right arm). There 
was more DNA in the arms than in the floxed region in order to enhance Cre 
recombination at the target. The 30 kb Jarid1c transcript sequence (ENSMUST 
00000082177) was aligned, using coverage information from Celera strains (information 
from Dr.Daniel Rios, EBI), against 129S1/SvImJ and 129X1/SvJ. As shown in figure 
39, there was we were unable to get sequence information for 129S1/SvImJ that covered 
the left arm homology region from the C57/Bl6 strain. However, 2.7 kb of sequence 
information were available for the 129X1/SvJ strain and these were 100% homologous to 
the C57/Bl6 sequence information. In the case of the right arm, no sequence information 
from the 129S1/SvImJ strain was available in this region. For the 129X1/Sv strain, the 
3.9 kb coverage information available was homologous to the region from C57/Bl6 
(Figure 56). 
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     (A) Design of Jarid1c targeting vector based on Southern blot strategy 
 
 
 
(B) Alignment results of 24kb transcript from C57/Bl6 against two 129 substrains  
 
 
Figure 56 (A) For the convenient southern blot analysis of recombinant and wild type 
Jarid1c alleles, we selected the KpnI restriction site. Depending on the presence of these 
restriction sites in the wild type Jarid1c allele, and on the specific probe coordinates, we 
determined the suitable regions for the 10 kb homology left and 10 kb homology right 
arm for the vector. 
(B) 30 kb Jarid1c transcript sequence from C57/Bl6 was aligned against two 129 
substrains, 129S1/SvImJ(not shown) and 129X1/SvJ. For the homology arm regions, no 
sequence data was obtained from the Celera 129S1/SvImJ strain. As for the 129X1/SvJ 
strain,7.3 kb sequence information for left, and 6.1 kb information for the right arm were 
missing. On the other hand, 2.7 kb left region and 3.9 kb right region sequence 
information of 129X1/SvJ showed 100% homology to the C57/Bl6 sequence information.  
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Subcloning of the 21.9 kb targeting the Jarid1c region into the 3.9 kb pACYC177 
was the last prokaryotic DNA engineering issue in this project. For the Red/ET 
recombineering to generate the Jarid1c targeting construct, a 3.9 kb minimal vector was 
amplified with specific primers that flanked the homology arm which corresponds to the 
targeting vector and the restriction enzyme NotI, using pACYC177 as a template. 
Through homologous recombination in the prokaryotic system, the Jarid1c targeting 
backbone was cloned to a minimal vector version of pACYC177 (Figure 57). The 
candidate recombinant clones were picked using BSD (5μg/ml) and ampicillin 
(100μg/ml) selection, and restriction enzyme analysis and sequencing was then used to 
find the correct recombinant clone (Figure 58). 
 
  
 
Figure 57 Subcloning the targeting backbone into the linear pACYC 177 
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 To generate the targeting vector, pACYC177 derived minimal vector was 
amplified with 5’ C (homology arm to BAC vector) NotI A (20 nt primer of pACYC177), 
and 3’ NotI and E (homology arm to BAC vector). Via Red-ET recombination, the 
targeting BAC region ExonI-Exon7 was cloned into the pACYC177 
 
 
 
Figure 58 (A) Verification of pACYC-Jarid1c subclones 
Restriction analysis of pACYC177-Jarid1c subclones after NcoI digestion. The restriction 
pattern of pACYC177-Jarid1c for NcoI is 281bp, 473 bp and 631 bp (not shown), 
1397bp, 1949bp, 2295bp, 2440bp, 3062bp, 3217bp, 3484 bp and 4964 bp. Among these 
different subclones, the correct one was verified with sequencing analysis of the 1 kb left 
and 1 kb right mammalian homology arm of the Jarid1c backbone.  
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Figure 58 (B) Verification of pACYC-Jarid1c sublones 
Restriction analysis of pACYC177-Jarid1c subclones after BamHI digestion. The 
restriction pattern of pACYC177-Jarid1c for BamHI is 348(not shown), 758 bp, 1168bp, 
1186bp, 1324bp, 1566bp, 1698bp, 2105bp, 2986 bp, 4291 bp and 6763 bp. Among these 
different subclones, the correct one was verified with sequencing analysis of the 1 kb left 
and 1 kb right mammalian homology arm of the Jarid1c backbone.  
  
 
To target Jarid1c through homologous recombination, the targeting vector was 
linearized with NotI and electroporated into E14TG2a cells. 3 rounds of electroporation 
were performed (Figure 59). 24 hours after the electroporation, BSD selection (5μg/ml) 
was performed for 14 days, then undifferentiated clones were picked from the 96 well 
plates and later expanded to 24 well plates. 
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Figure 59 Jarid1c gene targeting experiments 
The Jarid1c targeting vector was linearized with NotI. NotI digestion of the pACYC177-
Jarid1c subclone gave the 2.204 kb the pACYC177 vector backbone, and the 21.989kb 
Jarid1c targeting backbone. All DNAs were purified using phenol-chloroform. Lane 3 is 
undigested pACYC177-Jarid1c subclone, lane 4 is digested pACYC177-Jarid1c vector 
before DNA purification and lane 5 is the digested pACYC177-Jarid1c subclone used for 
electroporation of the EScells.   
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The 114 candidate recombinant clones from the 3 electroporations were screened 
by southern blotting (Figure 60). Southern blotting probes were designed with a special 
bioinformatics software tool, CENSOR (www.girinst.org/censor, Jurka J. et al), that 
screened query sequences against a reference collection of repeats and masked 
homologous regions with masking symbols, as well as generated a report classifiying all 
found repeats. In this project, the candidate left and right Jarid1c probe regions were 
analyzed with the vertebrate and mammalian reference collection of repeats and masks. 
This showed that the candidate right probe regions were not suitable and that the left 
probe regions had a couple of target sites that did not show repeats.  One of the candidate 
left probe regions was selected and the probe was designed from it. Additionally, the 
probe was blasted against the genomic sequences of Jarid1d, a homologue of Jarid1c. The 
blast results indicated that the probe could only recognize the X chromosome region of 
Jarid1c gene. 
 
The last targeting experiment was conducted with feeder dependent mouse ES 
cells, IB10 from the E14 origin. This showed 50 clones were the product of illegitimate 
recombination instead of homologous recombination. 
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Figure 60 Southern blot analysis of the Jarid1c allele 
Representation of southern blotting of wild-type and mutant Jarid1c alleles (upper). BAC 
or genomic DNA from were digested with KpnI enzyme and then hybridized with the 
specific probe (584 bp). The wild type allele was identified by a 24.9 kb fragment and the 
mutant allele was identified by a 11.9 kb fragment. Recombinant and wild-type allele 
bands were observed (left). The cassette was correctly inserted into the first intronic 
region of the Jarid1c gene. The Southern blot was probed with the left probe of the KpnI 
digested genomic DNA from wild type and different targeted clones confirmed that the 
gene could not be targeted; all BSD resistant clones were the product of illegitimate 
recombination. 
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3. DISCUSSION 
 
3.1 Efficient Trapping of the EGFP Transcript by A Generic FLEx 
Cassette 
 
Gene expression is not solely regulated by RNA polymerase II transcription 
efficiency or RNA polymerase II dependent transcription termination. Other factors have 
a significant effect on gene expression levels and control gene transcription in 
coordination with RNA polymerase II transcription. Chromatin state can also seriously 
impact transcription and pre-mRNA processing events are essential to regulation of gene 
expression. In summary, the state of the chromatin where a gene is located and the 
interaction between RNA polymerase II transcription and pre-mRNA processing events 
are prominent features that coordinate to positively or negatively influence gene 
expression. 
 
In this PhD project, FLEx was engineered to control the expression of a wide range of 
endogenous mouse genes by affecting RNA processing events. We found that efficient 
splicing and polyadenylation were the two main criteria that need to be fulfilled by the 
mutagenic oriented FLEx gene trap cassette. When the cassette was inserted into the first 
intronic region of any mouse gene in the same direction of its promoter, the cassette 
served as a synthetic terminal exon because the sA and pA signals of the cassette were 
recognized by the pre-mRNA processing machinery. These exogenous pre-mRNA 
processing signals prevented recognition of the endogenous sA and pA. This prevented 
the trapped gene from being transcribed downstream of the cassette insertion region. It is 
now clear from the work presented here that when building a gene trapping cassette to 
create RNA transcript level mutations it is important to consider the contribution of 
splicing and polyadenylation signals. Because these signals are so important for efficient 
mRNA processing both their structure and proximity to each other should be verified. 
 
Constitutive or alternative intron splicing is very critical for co-transcriptional events 
that ensure correct protein production via reliable mRNA processing. In a coordinated 
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manner, the splicing machinery elements recognize and load on to specific sequences at 
the 5
I 
(splicing donor) and 3
I
 (splicing acceptor) ends of introns. The splicing mechanism 
is very complex in higher eukaryotes, but in general it starts with the formation of a of 
complex ribonucleoproteins, called the spliceosome. In higher eukaryotes this mechanism 
requires more protein-protein interactions. The formation of this complex at specific 
splice site regions is enhanced by recognition of 5
I
 splice site through U1 snRNP, 
followed by recognition of the branch point by the branch point binding protein SF1 and 
the U2AF helper protein, and recognition of the 3
I
 splice site by U2 snRNP. snRNPs U4-
U6, excluding U3, are also involved in pre-mRNA splicing. 
 
Vertebrate splicing complexity is greater in comparison to other eukaryotes because 
vetebrate genes are more intricate. They often have very large introns and multiple small 
exons that average at 137 nucleotides (9). This exon-intron architecture makes 
exon/intron boundries more difficult to identify. Therefore spliceosome assembly 
requires a well-defined and strong recognition region. Splicing efficiency is determined 
by two factors (1) distance between specific splicing signals including the splicing donor, 
branch sequences, polyprimidine sites and the sA, and (2) their relative strength which is 
determined by the presence of an uninterrupted polypyrimidine tract. Based on the exon 
definition theory, exons are first recognized as a unit during the early assembly by factors 
that recognize and bind to the 3
 I
  end of intron (SD), and then the search for the splice 
acceptor begins. This suggests that direct communication occurs between the factors that 
recognize splice donor and acceptor sites (9,58,75). 
 
To maintain this precise communication and prevent exon skipping, the minimum 
distance between the splice donor and splice acceptor sites is required to be about 100 
nucleotides in length (personnel communication with Juan Valcarcel). In this study, 
the FLEx cassette contained a synthetic splice site that was composed of a consensus 
branch site, a pyrimidine rich region and splice acceptor. The proximity of the branch site 
was 887 bp to the downstream splicing donor and 27 bp to the upstream acceptor region, 
the optimal distances (111). In addition to the appropriate distance between splice 
recognition sites, the uninterrupted polyprimidine tract was an important component of 
 114
this cassette as it prevented the splicing machinery from skipping the synthetic terminal 
exon generated by FLEx in the intronic region of pCAGGS-EGFP-Neo. 
 
Another important factor affecting transcription is proper polyadenylation. A pA tail 
is found on nearly every processed mature mRNAs in vertebrates. It functions to stabilize 
mRNA, aids its transport from nucleus to cytoplasm, and promotes translation efficiency. 
Precise pA signals influence the recognition of the polyadenylation machinery elements 
and enhance efficient 3
I
 end formation of the newly synthesized pre-mRNA. These 
signals are composed of a consensus sequence, usually A residues at the 5
I
 site and GT/T 
rich sequences at the 3
I
 site. The distance between these two sequences determines the 
strength of pA signal and thus robust mRNA end formation. The approximate distance 
between these two cleavage and pA addition signals should be 20-40 nucleotides in 
length, a criteria fulfilled by the FLEx cassette synthetic pAsignal (18,19). These 
sequences are recognized by specific proteins; the CPSF factor interacts via its large unit 
with the A residues and the CstF factor recognizes and binds to the GT/T rich region. 
These factors involved in polyadenylation are composed of several subunits. 
 
Many experiments conducted on transcription and RNA processing machinery in 
yeast and mammalian cells have revealed a connection between these two events. This 
indicated that these factors associated with pre-mRNA 3
I
 end processing, cleavage and 
poly(A) tract formation, interact through their subunits with constituents of other 
processing events such as splicing (9,58). In particular, important support for this 
hypothesis has come from the isolation of factors involved in both polyadenylation and 
splice regulation, as well as in the recognition of the 5
I
 splicing site of the exon. The U1A 
protein is well known for playing a role in the regulation of these two events. It was 
found that SR proteins, key regulators of the 5
I
 splice site selection have a connection 
with polyadenylation. They have rich arginine - serine domains (RS) and through these 
domains they interact with U1A and U2A snRNPs and other proteins composed of this 
RS units such as the polyadenylation cleavage factor, CFI. These factors bind the 
enhancer sequence of the exons or alternatively directly bind to the exon splice site. In 
addition to promoting recognition of the exon by the splicing machinery, they activate 
polyadenylation cleavage (57). One study of calcitonin pre-mRNA processing claimed 
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that polyadenylation possibly communicates with splicing through SR proteins and that 
this may enhance polyadenylation. How is this possible? According to a study in human 
thyroid cells, the SRp20 factor binds to an enhancer region consisting of the 5
I
 splice site 
of exon 4 preceded by a pyrimidine tract. The 5
I
 splice site is recognized by U1 RNA 
(one of the small nuclear proteins) and other splicing machinery members. The 
polyadenylation cleavage factor CFI also consists of serine and arginine dipeptides.  
Interaction of these two SR proteins enhances polyadenylation at the 5
I
 splice sites. 
Mature mRNA structure of calcitonin in thyroid cells includes exon1-4, although the 
primary transcript has 6 exons. In this theory, this suggests that SR proteins can influence 
pre-mRNA processing at the level of polyadenylation and generally participate in the 
recognition of terminal exon, referred to in this PhD study as “last exon recognition”. 
Although all these observations were built on assumptions, they are highly suggestive of 
cross-talk between splicing and polyadenylation (57,83). 
 
Given the above data, we think that communication between elements requires that 
they are located in regions that enable them to recognize their binding sites, and that 
promote efficient splicing and polyadenylation. In this scheme, certain distance 
requirement between the splicing signals and poly A signal recognition factors must be 
observed. Based on the exon definition theory, terminal exons, namely both first and last 
exons in vertebrates, and internal exons are recognized by different mechanisms. The 
recognition of the terminal exon, referred to here as the last exon, is dependent on an 
interaction between the splice acceptor and polyadenylation factors U1 and U2snRNP at 
a 3
I
 splice site recognizing factors U2AF and SC35 (9,75). In order to promote this 
interaction, at least 100 nucleotides length distance should be generated between the sA 
and pA in the FLEx gene trapping cassette, similar to the proximity required between 
splicing components (personnel communication with Juan Valcarcel). The splicing 
failure seen in the first series mutagenic oriented FLEx-EGFP-Neo constructs could have 
resulted from the failure to observe such distance requirements. In this case, the distance 
impacted not only the recognition of splicing and polyadenylation signals but disrupted 
precise communication between the synt pA and synt sA signals is normally critical for 
recognition of the synthetic terminal exon in the FLEx cassette. Consistent with distance 
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being important, insertion of IRES-RFP sequence between the sA and pA in the cassette 
reversed this splicing failure. In this case, mutagenic oriented FLEx was able to capture 
the downstream region of the transcript and prevented EGFP expression. 
 
We next tested if a the FleX cassette containing the IRES-RFP may possibly fail to 
mutagenize due to effects of synthetic exon length on splicing, as suggest by a previous 
study (87). The GFP assay results showed that this was not the case. Additionally, we 
considered that the increased distance between lox sites generated by IRES-RFP insertion 
could decrease the cassette inversion capacity (27). However, Cre recombination 
efficiency test results in selected clones stably transfected with this cassette indicated that 
the cassette is competent in both orientations. We were also aware that intronic insertions 
could mainly result from alternative splicing, but we did not detect any alternative 
splicing. Nevertheless, it was difficult to determine the cassette orientation because of 
poor RFP expression following the electroporation. In contrast to the transient 
transfection results, poor, and/or nearly no expression of the RFP marker gene was 
observed in mouse E14TG2a cells transfected with the second series of mutagenic 
oriented FLEx-IRES-RFP-EGFP-Neo. This could be attributed to the low emission rate 
of the DsRed (RFP) marker gene that is used in the second cassette series and to slower 
fluorescence maturation compared to EGFP in mammalian cells. The advantage of using 
IRES for this kind of study is that translation of the reporter gene is independent of the 
endogenous initiation codon. RFP translates from the IRES start codon. It is also possible 
that IRES may be inefficient in this application as it has not been tested in ES cell studies 
prior to this project. This could explain the expression failure.  
 
3.2 The presence of mammalian transcription termination signals 
provides high fidelity to the mutagenic oriented FLEx 
 
Gene expression control through a recombinase mediated gene trapping cassette is 
not unique to this PhD project. Two other research groups generated gene trapping 
cassettes for conditional gene inactivation based on recombinase mediated unidirectional 
DNA inversion (91, 128). Dr. Xin’s research group (128) constructed a reporter cassette 
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composed of a strong and functional sA, the human bcl2 intron2/exon3, an EGFP 
reporter gene and the bovine growth hormone pA signal, all flanked by mutant and wild-
type lox sites placed in a configuration to enhance Cre mediated cassette exchange. In the 
pCAGGs-revGI-nlsDsRED vector construct, this cassette was inserted into the first intron 
of -actin downstream of the CAGGs promoter in an anti-sense configuration, neutral at 
the expense of splicing, polyadenylation and EGFP expression. DSRed sequences with 
the nuclear localization signal nls were placed downstream of the cassette in a sense 
configuration with the CAGGs promoter. In the pCAGGs-GI- nlsDsRED  vector 
construct, the cassette was placed in a sense orientation that allows the it to actively 
participate in mRNA processing events and results in EGFP expression. When HEK293 
cells were transiently transfected with the pCAGGs-revGI-nlsDdRed vector, only DsRed 
gene expression was observed 24 hours after transfection. In the anti-promoter oriented 
cassette, the RNA processing elements were neutral and not recognized. Thus the cassette 
had no effect on DsREd gene transcriptional activity. Whereas, in cells transiently 
transfected with pCAGGs-GI-nlsDsRED vector, the sense oriented cassette captured the 
DsRed transcript in the presence of functional sA and pA. Based on these experimental 
results, the gene trap cassette is reliable in both orientations. The antisense oriented 
cassette was totally neutral, it did not interfere with downstream gene transcription. On 
the other hand, the sense oriented cassette created a mutation at the RNA processing level 
that prevented downstream DsRed transcription. 
 
Following Cre-mediated cassette inversion in both kinds of transfected cells, the 
results contradicted previous outcomes.  After Cre plasmid co-transfection, the reverse 
oriented cassette turned and GFP expression was seen in the cells 24 hours after 
induction. At the same time, both RFP positive clones were seen along with yellow 
clones, both RFP and GFP positive (128). In the case of sense oriented cassette inversion, 
transfected cells expressed GFP following Cre induction although it was previously 
shown that antisense oriented cassette transfected cells were only RFP positive. All these 
contradictions could result from the transient transfection method used to introduce the 
trapping cassettes and Cre plasmids. These plasmids may not have integrated into 
genome in a stable way and thus were temporarily expressed and lost. At the same time, 
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it would be very convenient to make stable cell lines with the same constructs and Cre 
plasmid using electroporation to avoid the limitation of transient transfection efficiency. 
Dr.Schnutgen’s research group generated another kind of gene trapping cassette, 
pFlipROSA-geo, that totally distrupted the retinoblastoma gene through a first intronic 
insertion (91). Thus the question is, which part the FLEx cassette, developed in our 
laboratory, distinguishes it from other cassettes used in the same gene trapping strategy? 
 
In this PhD study, the gene trapping strategy was innovative for two major 
reasons: (1) high mutagenesis capacity at the level of transcription due to the utlization of 
mammalian transcription termination signals; and (2) amenability to Cre-mediated 
recombination. The first generation of FLEx cassettes did not prevent the production of 
downstream EGFP mRNA when inserted antisense into the first intron of the -actin 
gene. Thus the cassette was reliable in terms of neutrality. The failure of the mutagenic 
oriented cassette only stemmed from the unfavorable arrangement of the splice  acceptor 
and polyadenylation signal in the cassette. The distancing sA and pA in the cassette by 
adding IRES-RFP prevented this pitfall. Both ES cells both stable and transient 
transfected with mutagenic oriented FLEx cassettes confirmed this fact. Remarkably, 
neither transfection nor Cre efficiency seemed to interfere with the expected results in 
stable E14TG2a clones containing either orientation of the FLEx cassette at 24 hours 
after transient transfection of the Cre plasmid. Indeed, high frequency of cassette 
inversion seen 24 hours after lipofectamine transfection of the Cre plasmid showed that 
although the risks of unstable Cre integration and expression are still present, they did not 
affect this particular experiment. 
 
  This project was aimed at developing a versatile tool to for large-scale 
mutagenesis in the mouse. This objective requires that the cassette is able to control 
complex and highly coordinated transcriptional events in mammalian systems. In both 
yeast and mammalian systems, transcription termination, the last stage of RNA Pol II 
transcription that involves dissociation of both the newly synthesized pre-mRNA and 
RNA pol II enzyme from the template DNA, has a regulates gene expression as well as 
splicing and polyadenylation. Although a functional pA signal is necessary for effective 
transcription termination, RNA pol II does not terminate at the pA signal. In vitro 
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experimental systems coupling RNA pol II transcription and polyadenylation pointed out 
the pA signal only directs the slowing down of the RNA pol II enzyme. Therefore, we 
designed the FLEx cassette with the special signals that enhance transcription 
termination. 
 
One remaining question to be answered in this project was, Are the transcription 
termination signals really necessary for the mutagenicity of the cassette? To determine 
this, FLEx gene trapping cassettes were engineered without these signals and assayed 
with GFP. The absence of the signals did not affect the neutral character of the cassette, 
as expected.  However, in the sense orientated FLEx cassette, the absence of the signals 
positively affected downstream EGFP mRNA transcription. GFP expression is not 
normally seen in cases of mutagenesis by this cassette. This means that the cassette lost 
its mutagenic character in stable transfected E14TG2a cells, indicating that the 
termination signals are a critical part of the cassette. 
 
In conclusion, efficient splicing and polyadenylation have key roles in controlling 
expression of the trapped gene. In particular, the termination signals downstream of the 
pA signal served as check point factors. 
 
3.3 CoTC is a strong component of mammalian transcription 
termination 
 
The usage of the transcription termination signals, CoTC and MAZ4, was the 
novel part of this PhD project. Neither of these signals had previously been applied in this 
way. Moreover, there had not been any scientific evidence showing the dominance of 
CoTC versus MAZ4 in transcription termination. Mammalian transcription termination, 
in additional to translation control, strictly coordinates the response to protein demand. 
Proper transcription termination is critical not only to preventive the production of 
truncated mRNA due to early stoppage of Pol II enzyme, but to regulate neighbouring 
gene expression by preventing a late Pol II stop. In mammals this process is less 
understood than other transcription stages. Further studies are required to untangle this 
complexity. 
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Two main models have emerged to describe the mechanism of transcription 
termination, the anti-terminator and the torpedo model. Recently, one group indicated 
that the actual mechanism is a combination of these two models. This is based the 
discovery that termination showed extensive heterogeneity in most mammalian genes, 
occurring at various positions along the pA signal instead of at a single site. This supports 
a requirement for heterogenic auxillary termination elements such as CoTC in the  
globin gene or MAZ4 in the C2 complement gene downstream of the poly A signal for 
the control of gene expression (36,107). 
 
In this study, we used the different combinations of CoTC and MAZ4 to find out 
what works best to create a total mutation at the RNA transcription level. GFP assay 
results with the second generation of mutagenic FLEx cassettes indicate that successful 
EGFP trapping occurs in the presence of CoTC rather than MAZ4. MAZ4 operated at a 
rate that was 50 % less than CoTC. These observations were further supported theabsence 
of GFP expression in E14TG2a cells transfected with a mutagenic FLEx cassette 
containing the BSD marker gene and CoTC. It is possible, however, that this principle 
does not universally apply to all mammalian genes. In other ES cell types, and/or in other 
gene, MAZ4 may be useful for preventing Pol II sliding down the RNA. After presenting 
our lastest findings with the FLEX constructs containing BSD selection marker at the 
EUCOMM February 2006 meeting, Dr. Proudfoot’s research group announced that the 
strong four G repetitive sequences, MAZ4 were not sufficient to promote transcriptional 
termination (36). This result supported our results in mouse E14TG2a ES cells. They 
tested MAZ4 in the -globin gene by substituting it for CoTC, 800 bp downstream of the 
pA signal and transfecting HeLa cells with this construct. They found that compared to 
CoTC, MAZ4 worked 57% less efficienctly in this gene. The -globin gene is part of a 
closely spaced gene cluster. In this cluster, the intergenic elongation of the pol II enzyme 
is controlled by pausing signals in genes such as G globin within the cluster on 
chromosome 11. The A globin gene in the same cluster has an identical pausing 
mechanism, but due to its weak pA signal, it is weaker than that of the G globin gene. 
Pausing activity is strongly dependent on a functional, strong pA signal (81). Our 
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observations that the mutagenic FLEx cassette with the MAZ4 signal is weak, illustrate a 
failure of weak pA signal within the cassette to reliably pause or slow the pol II enzyme. 
 
Proximity of the MAZ4 to strong pA signal was effective to complete 
transcription. This was expected as it has been shown that control of immunoglobulin 
gene termination in the presence of a pause site 1 kb downstream of the pA signal does 
not affect termination. The efficiency of MAZ 4 from 50 bp distance downstream of pA 
signal has also been tested and found to have no negative influence on pausing efficiency 
(80). However, the possibility of negative effect at very close distances has not yet been  
investigated. Trapping of GFP in the second (IRES-RFP constructs) and third generations 
of FLEx cassettes (BSD constructs) that contain both signals may result from the close 
distance. Placement of MAZ4 immediately downstream of the pA signal did not result in 
downstream GFP transcription capturing. On the other, placement of MAZ4 downstream 
of both the pA did not interfere with EGFP transcription termination. This suggests that 
MAZ4 may be enhancing termination in combination with CoTC. Of course in these 
experiments, CoTC function was independent of both pA proximity and strength, and the 
results seen here may have been due to this. 
 
This data raises the question of what pA signal types are utilized in the mouse 
genome. Investigations were done of pA signal variations among the mouse genes. Up to 
now, the most interesting and reliable pA signal mapping study was completed in 2005.  
Based on NCBI databases, including gene bank, Unigene, and dbEST, 16.282 pA sites 
were mapped in 11.255 mouse genes using the consensus hexamer AAUAAA or its 
closed variants and the heterogeneity of cleavage sites. This research concluded that gene 
function, structure, cell/tissue specificity, and the developmental stage of expression, 
direct preferences for pA signal type and usage (103). To make this choice, specific cis 
acting elements and trans acting factors are critical. Another investigation of the pA 
signal preferences in human genes turned attention to pA efficiency and the factors 
determining this preference. Indicators of pA strength are DSE structure and the distance 
of this U or G rich sequence to the pA, AAUAAA hexamer or its variations (54). 
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When we looked for pA signal usage preferences for the construction of an 
efficient gene trapping cassette, we found no published rules. For mouse mutagenesis, 
SV40 triple pA, bgh pA, and MMLV U3 pA are the most commonly used signals in gene 
trapping cassettes (111). The common feature of all these signals is that their strength 
depends on the distal proximity of the DSE to the pA signal hexamer. In this PhD project, 
it was not possible to test every kind of pA signal, but we can now offer some rules for 
uninterrupted cassette functionality. For conditional first multipurpose allele generation 
with FLEx, the first rule about the pA element in the gene trapping cassette is that it 
should be unidirectional so that it does not interfere with endogenous gene transcription. 
In this project, usage of the strong pA signal, bidirectional SV40pA, in the third 
generation of neutral oriented FLEx cassettes was important to monitor the dangerous 
effects of SV40pA. The percentage ES cells that expressed GFP was 50 % decreased in 
the presence of SV40 compared to the synthetic pA signal. For large-scale gene trapping 
events, incorporation of a functional, but not necessarily strong, pA element in along with 
an efficient transcription termination signal, such as CoTC, will be practical. 
  
3.4 Gene targeting – definite but not accurate for all routine mouse 
genome manipulations 
 
Here, we tested the gene trapping FLEx cassette by integrating it into the -actin 
intronic region of the CAGGs-EGFP-Neo construct. The best configuration of the FLEx 
cassette was determined by assaying GFP expression in FLEx cassette series-transfected 
E14TG2a ES cells. The FLEx cassette is now ready to use for targeted trapping. It has 
strong RNA transcript processing signals (synt sA and synt pA), a reliable terminator 
signal (CoTC), a suitable marker gene for mammalian systems (blasticidin), and is able to 
be utlized with Cre recombination. It is also reliable in both orientation. 
 
To simplify this application, we selected the X-linked Jarid1c gene, which is 
single-copy in male E14TG2a ES cells from the 129 Ola strain. Our first goal was to 
generate a Jarid1c conditional allele via single step homologous recombination. 
Unfortunately, homologous recombination with the successfully engineered and 
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subcloned Jarid1c BAC targeting construct was not achieved in E14TG2a ES cells. The 
major limitation of this strategy was the high rate of random vector integration. 
 
Gene targeting is dependent on sequence similarity (homology) between the 
exogenous DNA (targeting construct) and  the endogenous DNA (targeted gene locus). 
Gene targeting is the preferred to strategy to specifically modify of mouse genome. 
However, it is still impractical for routine applications. This application is totally 
dependent on endogenous cellular DNA rearrangement machinery, such as the repair 
system. Compared to other eukaryotic organisms, like drosophila and yeast, the 
frequency of homologous recombination during foreign DNA integration into the 
targeted locus is extremely low versus illegitimate recombination, 1000-10.000 times less 
frequent. The versatile targeting ratio is infinite because the preferences of recombination 
type during foreign DNA integration into the mammalian genomes, as well as the factors 
directing these preferences, are still ambiguous. In addition to cellular factors, 
experimental factors influence targeting frequency and exhibit variability from gene to 
gene. Analyzing previous attempts to increase gene targeting helped to clarify the reasons 
behind the Jarid1c targeting difficulties. We focused on putative factors that impede 
targeting, like an impervious gene locus, improper targeting construct, poor ES cell 
conditions or inefficient construct delivery. 
 
Chromatin status and Jarid1c expression levels were critical considerations during 
the planning stage of Jarid1c targeting in male ES cells. Affymetrix gene chip expression 
data from Dr.Sandra Lubitz (personnel communication) indicated that Jarid1c is 
expressed in E14.1 (129 strain ES) cells. In addition, the gene was trapped in a random 
fashion in C57BL/6Jx129S6/SvEvTac F1 derived ES cells. All these were male origin 
(39,91). In this project, we used E14 (129 strain) ES cells. In contrast to the expected 
results of homologous recombination, we found that illegitimate recombination always 
occurred between the trapping exogenous cassette and the first intronic region of the 
gene. Therefore the possible negative effect of an imperveneous gene locus was not the 
reason for recombination failure in the previous study. Unfavourable distribution of 
heterology between the targeting vector and targeting locus may be the culprit (23). In 
this project, our Jarid1c BAC DNA source was from the C57BL/6J strain, the only 
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alternative strain that has been annotated in the Ensembl genome information. We also 
increased the length of homology arms on the targeting construct. This was not expected 
to cause problems in nuclear diffusion efficiency because a previous study indicated that 
10-25 kb arm length has no effect (23). We also determined the sequence divergence of 
both arm regions from C57BL/6J and two substrains of 129 DNA. The 30 kb Jarid1c 
transcript from C57BL/6J was aligned against 129/SvlmJ and 129/SvJ (sequence 
information Daniel Rios from EBI). Information from 129 substrains was not available 
for 7.3kb of theleft arm and 6.1kb of the right arm. In summary, we could not obtain 
information about the homology arm from the 129 DNA source. In this case, the left 
homology arm length could be 2.7 and right arm could be 3.9 kb. The probable high 
degree of heterogeneity on the homology arm could complicate Jarid1c targeting. 
 
For mouse genome modifications, ES cells are always the preferred cell type. 
Activity and duration of the cell cycle is dependent on the cell state. ES cells are highly 
proliferative due to more than half of its cell cycle being the S phase. Gene trapping is 
dependent on the homologous machinery that is mostly active in the cell cycle phase 
G2/S. Therefore, a high rate of homologous recombination is found in ES cells. However, 
ES cells can lose this state. Sponatenous differentiation comes from high passage rates 
and potential from the enzymatic passaging method. Trypsin treatment may create such a 
handicap for gene targeting (29). For the second targeting, we used more healthy, highly 
proliferative and less passaged IB10 cells. Unfortunately, this did not change the 
targeting fidelity of this gene.  
 
Our last experimental consideration for the Jarid1c targeting case was the 
technical efficiency of ES cell transfection. DNA delivery method is another essential 
factor that influences the chance of foreign DNA integration into the host genome. The 
main parameters for high efficiency transfer of nucleic acids to specific mammalian cells 
are low toxicity, the ability to keep the nucleic acid stability, and the practicality of usage. 
Common DNA transfection methods can be classified as: chemical (DEAE dextran, 
calcium phosphate-DNA co-precipitation, liposome mediated DNA transfection); 
physical (electroporation, direct microinjection of DNA); and viral (infection). The 
disadvantages and advantages of each of these delivery methods is clear, but information 
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is limited on how they affect transfection efficiency and DNA stability. There is no 
information about how they influence nuclear events, e.g., recombination following 
exogenous DNA transfer. 
 
In this project, we used electroporation to transfer DNA into the cytoplasm by 
emitting electric pulses that affect cell permeability. Its efficiency has been proven in 
mammalian cells (31). However, whether electroporation can affect DNA stability in 
cytoplasma and its transfusion into the nucleus is a key question in gene targeting studies. 
In 1980, when mammalian gene targeting studies first started, one study indicated that 
DNA directly microinjected into the host cells stably integrates in only 20% of the cells. 
Electroporation is more advantageous than this because it results in a larger number of 
transfected cells (10,31). Today, transfection rate has been improved thanks to advanced 
nucleic acid delivery techniques. However, the problem still remains that these 
techniques introduce exogenous DNA into the cytoplasm but they can not affect nuclear 
transfusion. One research paper showed that foreign DNA is rapidly degraded upon 
transfection (110). In nucleus, it is not clear if it undergoes modifications such as large 
deletions and point mutations, before or after integration into the genome (110).  It was 
also shown that foreign DNA in the nucleus can be efficiently circularized, but only in 
the case of microinjected DNA (110).  Unfortunately, nuclear events cannot be controlled 
by the today’s transfection methods. These uncontrollable events might have played a 
role in our Jarid1c targeting difficulties. 
 
Another potential reason for this targeting failure could be the presence of 
illegitimate recombination hot spots on the mammalian chromosomes. Major groups are 
now working on the molecular mechanism of the illegitimate recombination and the 
tendency of the specific DNA regions to promote these kind of genetic arrangements 
(10,91). It was possible to trap the intronic region of Jarid1c between coordinates 
147.574.367-147.574.426 on the X chromosome using the intron trapping cassette, 
rFlpROSABetaGeo (91), but it was impossible to target the intronic region of Jarid1c 
between coordinates 147.577.072-147.577.167 using the FLEx-Jarid1c targeting 
construct. This difference may be an example of a hot spot effect. 
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In summary, our work has produced a gene trapping cassette that shows high 
fidelity in GFP trapping. We also have demonstrated that transcriptional events and 
elements enhance mutagenesis capabilities of the FLEx gene trapping cassette. This was 
a novel finding for gene trapping application. In the future, it will be important to direct 
homologous recombination in ES cells by exerting control over nuclear events. Dr. 
Dominguez-Bendala’s effort to increase targeting frequency in ES cells through 
transfection of the Rad51 plasmid was the fascinating example for this theory (24). 
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4. METHODS 
 
4.1 DNA protocols 
 
4.1.1 Small-scale preparation of plasmid DNA 
 
This protocol has 3 basic steps; (1) alkaline lysis of bacterial cells with SDS, (2) 
plasmid DNA isolation, and (3) washing and purification of the plasmid DNA. From a 1 
ml culture, the typical yield for high-copy plasmids (pUC, pBluescript vectors) is up to 
20 μg, for mid-copy (pACYC and derivatives) and low-copy plasmids ( pSC101 vectors) 
it is 10-15 μg. Bacterial culture volume can be 2 ml for low-copy plasmids. Further 
information for other critical considerations such as construct size can be gathered from 
Gene Bridges Company. 
 
 Inoculate a single colony into 1 ml LB with suitable selection agents, antibiotics, and 
incubate at 37
0
C with vigorous shaking (~1000 rpm) 12-16 hrs. 
CRITICAL: If the selection agent is blasticidin, please use low-salt LB with pH 8.0. 
 Spin the overnight culture 1 min at 13,200 rpm at RT, remove the supernatant and 
resuspend the bacterial pellet in 200 μl buffer P1. 
 Add 200 μl buffer P2 and mix by inverting, at this point 5 min RT incubation can be 
done for proceeding the lysis reaction but no more than 5 min.  
 Add 200 μl buffer P3 and mix by inverting. It can be left on ice for 20 min. 
 Spin 20 min at 13,200 rpm at rt, transfer the supernatant into an eppendorf tube 
containing 600 μl isopropanol. Vigorously mix and spin at max speed, 13,200 rpm for 20 
min at RT. This precipitates the plasmid DNA  
Wash the pellet 75% ethanol, spin 1 min at 13,200 rpm at RT. Then remove the 
alcohol. 
 Dry pellet at 5 min 450C, then redissolve the DNA in a suitable volume of buffer, 20-
30μl (TE, pH 8.0 for long term storage, 10mM Tris-Cl, pH 8.5 or sterile water). 
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4.1.2 Large-scale preparation of plasmid DNA 
 
This procedure is based on a modified alkaline lysis of bacterial cells followed by 
binding plasmid DNA to an anion-exchange resin under low salt and pH conditions. 
RNA, proteins, dyes, and low-molecular-weight impurities are removed by a medium-salt 
wash. Plasmid DNA is eluted in a high salt buffer and then concentrated and desalted by 
isopropanol precipitation. Plasmids up to approximately 150 kb can be purified with this 
method, but plasmids larger than 40-50 kb may show reduced elution efficiencies. From 
100 ml culture the typical yield for high-copy (pUC and pBluescript vectors) and mid-
copy plasmids (pACYC and derivatives) is 300-500 μg. The expected yield from 500 ml 
of low-copy plasmids (pSC101 vectors) is100-500 μg. Further information can be 
gathered from the Qiagen plasmid purification handbook. 
  
 Inoculate a single colony into 100 ml LB for high-copy, or 500 ml LB for low copy 
with suitable selection agents, antibiotics, and incubate at 37
0
C with vigorous shaking 
(~300 RPM) 12-16 hrs. 
CRITICAL: If the selection agent is blasticidin, please use low-salt LB with pH 8.0. 
 Harvest the bacterial cells by centrifugation at 6000 rpm for 15 min at 40C 
(Beckman JLA 16.250 rotor) 
 Resuspend the pellet in 10 ml buffer P1, vortex vigorously 
 Add 10 ml buffer P2, mix gently through inverting and incubate at rt for 5 min to 
complete lysis reaction. 
 Add 10 ml pre-chilled buffer P3 and mix gently through inverting.  
 Pour the lysate into the barrel of the filter cartridge, incubate at rt for 10 min. 
 Gently insert the plunger into the cartridge and filter lysate into the 50 ml falcon tube. 
CRICTICAL: If the DNA will be used for cell transfection or the other approaches 
similar sensitivity, endonuclease buffer (2.5 ml) has to be added into the filtered lysate, 
and incubate 30 min on ice. Then the rest of protocol steps should be followed. 
 Equilbrate the QIA-tip 500 by applying 10 ml QBT buffer and allow the column to 
empty by gravity flow.  
 Apply the lysate to the tip 500 and allow it to enter the resin by gravity flow. 
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 Wash the tip 500 with 2x 30 ml wash buffer, QC. 
 Elute DNA with 15 ml elution buffer, QN. 
 Precipitate DNA by adding 10.5 ml (0.7 volumes) isopropanol to the eluted DNA. 
Mix, and not necessary to immediate centrifuge. Incubation at rt increases the yield. 
 Centrifuge at 7000 rpm, 1 hr, at 40C  
(Beckman JS 13.1 rotor and 30 ml Corex glass tube with adaptor) 
 Wash the pellet with 5 ml %75 ethanol or 5 ml 70% endotoxin-free ethanol supplied 
by kit. 
 Air dry the pellet for 10 min, then then redissolve the DNA in a suitable volume of 
buffer, ~250-300 μl (TE, pH 8.0 for long term storage, 10mM Tris-Cl, pH 8.5 or sterile 
water). 
 
4.1.3 Mini-scale preparation of BAC DNA 
 
This protocol is designed for BAC DNA purification from 2 ml culture. Further 
information can be gathered from the Epicentre BACMAX plasmid purification 
handbook.  
 
 Inoculate the single colony into the 2 ml LB with suitable selection agents, antibiotics 
and incubate at 37
0
C with vigorous shaking (~1000 rpm) 12-16 hrs. 
CRITICAL: If the selection agent is blasticidin, please use low-salt LB with pH8.0. 
 Spin the overnight culture 1 min at 13,200 rpm at RT, discard the supernatant  
 Add 200 μl chilled BACMAX solution 1 to the pellet. Vortex vigorously to 
completely resuspend the pellet. 
 Add 400 μl BACMAX solution 2 to suspension, mix by inverting the tube 2-3 times 
very gently and incubate no more than 5 min at rt to complete lysis reaction. 
 Add 300 μl chilled BACMAX solution 3, mix by inverting the tube 2-3 times very 
gently. Incubate on ice for 15 min. 
 Centrifuge at max speed, 13,200 rpm for 15 min at 40C, transfer the supernatant in an 
eppendorf tube  
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 Centrifuge at max speed, 13,200 rpm for 15 min at 40C, transfer the supernatant in an 
eppendorf tube, add 540 μl (0.6 volumes) room temperature isopropanol, mix thoroughly 
by inverting the tube 4-6 times. 
 Centrifuge at max speed, 13,200 rpm for 15 min at 40C, carefully remove the 
isopropanol, dry the pellet at rt for 5 min. 
 Redissolve the DNA completely in 250 μl TE buffer. 
 Add 1 μl Riboshedder RNAse blend to the tube and incubate at 370C for 30 min. 
 Add 250 μl chilled BACMAX solution 4, mix thoroughly by tapping the tube and 
incubate on ice for 15 min. 
 Centrifuge at 13,200 rpm for 15 min at 40C.Transfer the supernatant to an eppendorf 
tube, add 1 ml of absolute ethanol to the recovered supernatant, mix gently by inverting 
the tube 4-6 times. 
 Precipitate the DNA by centrifugation at 13,200 rpm, for 15 min at 40C. 
 Air-dry the pellet at room temperature for 5 min, and then redissolve the DNA in 25 
μl (TE, pH 8.0, or 10 mM Tris-Cl or sterile water) 
 
4.1.4 Preparation of mouse genomic DNA from mouse E14TG2a cells  
from 6 well-plate 
 
  Aspirate the media from 6 well plates containing confluent ES cells, wash once with 
3ml PBS, aspirate. 
 
  Add 800 μl PBS, and scrape by a soft movement with sterile scraper. Take the cells 
with a micropipette and put into an eppendorf tube. 
 
  Alternative to the scraping, put 300 μl trypsin, incubate 1-2 min at 370C, then add 
300 μl medium to inactivate the trypsin. Put into an eppendorf. 
 
  Centrifuge at 4000 x g, at rt for 4 min 
 
  Wash with 1 ml PBS by spin at 4000 x g at 40C for 4 min 
 
  Remove PBS, put 1ml fresh PBS. Allocate 250 μl for genomic DNA isolation and 
750 μl for freezing to further aims. 
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  Add 500 μl lysis buffer and incubate overnight at 370C 
 
  Next day, put 500 μl phenol/chloroform/isoamylalcohol (25:24:1) and rotate 1 hour 
on a rotating drum. 
 
  Centrifuge at 10,000 x g at rt for 10 min, take the aqueous phase containing DNA 
carefully not to contaminate with lower phase protein, phenol. 
 
  Add 1 volume chlorophorm (1:1) approximately 400- 500 μl and rotate 1 hour on a 
rotating drum. 
 
  Centrifuge at 10,000 x g at rt for 10 min, take the aqueous phase containing DNA 
carefully not to contaminate with lower phase protein, phenol, chlorofom and other 
impurities. 
 
  Add 25 μl 3M potassium acetate, and 400 μl isopropanol, mix. Incubate for 5 min at -
80
0
C, centrifuge at 10,000 x g for 15 min at 4
0
C. 
 
  Wash the pellet with 75% ethanol, spin at 10,000 x g for 5 min at 40C. 
 
  Remove the ethanol, and dry the pellet for 5 min at rt. Add 100 μl TE buffer, pH 8 
and incubate in a water bath for few hours at 37 
0
C, then overnight at rt. 
 
                               
4.1.5 Preparation of mouse genomic DNA from mouse E14TG2a cells  
from 48 well-plate 
 
For routine analysis, it seems that the 6-well-plate approach is not practical, also 
the DNA concentration from 96 wells is not enough. Therefore, I modified the 48-well-
plate protocol from Yale University, Animal Genomics services. With this approach at 
least two rounds southern blot analysis is possible.  
 
  Aspirate the media from 48 well plates containing confluent ES cells, wash once with 
500 μl PBS, aspirate. 
 
  Add 150 μl lysis buffer, seal plate with parafilm, put in a box containing wet towel 
and incubate at 55
0
C for overnight. 
 
  Next day, transfer the lysate to an eppendorf tube, add 75 μl saturated NaCl and 
shake vigorously. 
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  Spin at 4000 x g for 15 minutes; transfer the supernatant to a new tube. 
 
  Spool out the DNA with a tip but it was cut not to shear the DNA. Wash  the  
pellet with 75% ethanol, centrifuge 10,000 x g for 5 min at  4
0
C. 
 
  Resuspend in 50 μl TE buffer, pH 8. 
 
4.1.6 Restriction Enzyme Digestion 
 
Restriction enzymes specifically cut plasmid and genomic DNAs into fragments 
for manipulation, analysis and further assays. Although each restriction enzyme has its 
own optimum conditions, some rules for the appropriate DNA digestion are universal. 
The most critical rule is that the DNA should be purified. As a rule, 1 unit of restriction 
enzyme cuts 1μg DNA in 1 hour. Actually, for plasmid DNA digestion, the enzyme unit 
should be two times (1μg DNA/2 unit enzyme), and for genomic DNA digestion, the 
enzyme unit should be 5 times higher than the DNA concentration (1μg DNA/ 5 unit 
enzyme). Incubation time and temperature is dependent on factors like enzyme type and 
the DNA nature. Further information about digestion conditions can be gathered from 
NEB, Stratagene, Andras Nagy laboratory, and Cold Spring Harbor protocol pages. Also 
critical points for suitable enzyme selection for genomic DNA can be read from Nagy 
pages. 
 
Analytical reaction        Preparative reaction (eg: fragment isolation, southern blot)     
DNA x μl(0.2-0.5μg)                                   DNA x μl(10-20 μg) 
10 X Buffer 1μl                                            5 X Buffer  5 μl 
R.E x μl (x unit)                                           R.E x μl (x unit) 
If necessary 0.1 X BSA                               If necessary 0.5 X BSA                                
Add to 10 μl sterile water                             Add to 50 μl sterile water 
 
4.1.7 Agarose gel electrophoresis 
 
Gel electrophoresis is a method to separate DNA, RNA or protein molecules by 
size. This is achieved by moving negatively charged nucleic acids through an agarose 
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matrix with an electric field at rates that are inversely proportional to the size, and 
conformation (linear or circular) of the molecules. Shorter molecules move faster than 
longer ones. From the slowest to the fastest, plasmids in different conformations migrate 
at different rates; nicked open circular DNA, linear DNA, relaxed circular DNA, 
supercoiled and the fastest, denaturated supercoiled DNA. 
 
Gel electrophoresis can be used for the separation of DNA fragments of 50 bp to 
several megabases. Small nucleic acids are better separated by polyacrylamide gel 
electrophoresis. Larger nucleic acids are better separated by pulse-field electrophoresis. 
For appropriate resolution, the agarose gel concentrations are summarized below.  
Linear fragment size                                    % agarose 
 30 kb to 15 kb                                                     0.4% 
 15 kb to   1 kb                                                     1% 
 2.5 kb to 0.5 kb                                                   2% 
  < 100 bp                                                             3% 
 
 
The most common electrophoresis buffers are Tris/acetate EDTA(TAE), the best  
for resolution of larger fragments, and Tris/Borate EDTA(TBE). As for the loading 
buffers, bromophenol blue is commonly used. 1x bromophenol blue is generally added to 
the DNA. For the BAC DNA electrophoresis, orange G is useful. The running voltages 
are 75 volts for plasmid DNAs  and 50 volts for BAC DNA. The rule is 5-10 volts/cm. 
DNA. The DNA is visualized by 20 ng/ml ethidium bromide.  
 
4.1.8 Phenol-chloroform extraction of plasmid DNAs 
                                                   
This technique is used for purifying DNA from proteins. Minimum start DNA 
volume  is 100 μl, a lower volume should be diluted with TE buffer or water up to 100 
μl. For the first step phenol:chloroform:isoamylalcohol(25:24:1) is added in a 1:1 volume 
to the DNA and mixed, small fragments can be mixed by vortex. Centrifuge for 5 min, at 
16,000 x g, at RT. The aqueous phase is removed, then 1 volume chloroform is added, 
mixed and centrifuged under the same conditions. Then DNA precipitation is performed. 
For this the final concentration of 0.3 M sodium acetate is added, mixed, and absolute 
 134
ethanol is added. Following the 5-30 min -80
0
C precipitation, the mix is centrifuged at 15 
min, 16,000 x g. The pellet is dried at 45
0
C for 5 min or at RT for 10 min, and 
redissolved in a suitable volume of TE, pH 8.0, 10 mM Tris-Cl or sterile water. 
 
4.1.9 Ligation 
 
DNA ligations are performed by incubating vector and insert DNA (DNA 
fragment from gel or PCR product) appropriately 1 (vector): 2 (insert) in the presence of  
T4 ligase buffer, enzyme and sterile water. The reaction volume is 10 μl. In this project 
either blunt end or sticky end ligation, 4
0
C reaction temperature (refrigerator) and 24 
hour incubation time were used. 
 
                               Ligation reaction 
                                 Vector DNA x μl  
                                     Insert DNA 2x μl  
                                      10 X T4 DNA ligase Buffer 1.07 μl 
                                          T4 DNA ligase 0.5 μl (5 unit)  
                                              Add to x μl sterile water to set up 10 μl 
 
4.1.10 TOPO TA Cloning 
 
TOPO TA cloning provides a highly efficient one-step cloning strategy for the 
direct insertion of  Taq polymerase amplified PCR products into a plasmid vector. No 
ligase, no post-PCR procedures (purification and precipitation) and no PCR primers 
containing specific sequences are required. 
 
                           Cloning reaction 
                                 Vector DNA 1 μl  
                                     PCR product  4 μl  
                                          Salt solution 1  
                                                Add to 5 μl sterile water to set up 6 μl 
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5 min-overnight incubation (30 min is generally enough) for cloning reaction. The salt 
buffer should be diluted 4 fold to prepare 300 mM NaCl, 150 mM MgCl2 if  
electrocompetent E.coli are used. 2 μl reaction sample is electrophorated or transformed 
into chemical competent E.coli. 
 
4.1.11 Polymerase chain reaction (PCR) 
 
 
This technique permits us eto xponentially amplifying specific DNA regions 
through enzymatic replication in vitro. PCR is carried out in 3 main steps; (1) 
denaturation of the template DNA, (2) primer annealing, and (3) extension/elongation. It 
consists of 20 to 35 cycles. 
 
In this PhD project, PCR was performed on a Stratagene Robocycler machine (2003) or 
an Eppendorf PCR machine (2005-2006).  
PCR mix (50 μ l rxn) 
 DNA template x μl (10 ng for plasmid DNA, 100 ng for genomics DNA)  
 dNTP  1 μl (10 mM) 
 F primer 1 μl (10 pmol)  
 R primer 1 μl (10 pmol) 
 5X Taq DNA polymerase buffer 5 μl 
 Taq DNA polymerase 0.5 μl (2.5 unit) and X μl water to complete 50 μl. 
Denaturation was always carried out at 95
0
C. 30 cycles were performed and annealing 
temperature was optimized based on the primer Tm for each reaction. The last cycle was 
always 10 min at 72
0
C.  
  
4.1.12 PCR product purification 
 
For the molecular cloning reactions, PCR products were purified using the 
agarose gel extraction method to obtain 70 bp- 10 kb DNA from standard of low-melt 
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agarose gel. For Red-ET cloning, PCR products were precipitated (section x DNA 
precipitation). 
 
  Cut the DNA fragment from agarose gel with a sterile scrapel  
  Weigh the gel slice, as a rule, add 3 volume of buffer onto the 1 volume of gel  
 (1 volume=100 mg ~ 100μl). 
  Dissolve the gel completely by incubation at 50 for 10 min, every 2 min mix by 
vortex.  
  Add 1 volume of isopropanol to the dissolved gel. This step increases the yield of  
DNA fragments < 500 bp and > 4 kb.  
  Apply the sample onto the QIA quick spin column, and centrifuge for 1 min at rt, at 
13,000 RPM. In order to remove the traces of agarose, 500μl  buffer QG can be  added on 
to the column and centrifuge done again for one min at rt, at 13,000 RPM. 
  750 μl buffer PE is added onto the column after 1 min centrifugation at rt at 13,000 
rpm, additional centrifuge repeated at the same condition to remove the alcohol 
completely. 
  30-50μl buffer EB (10 mM Tris-Cl, pH=8.5) or sterile water is added to the center of 
the column to elute the DNA. After 1 min rt incubation, centrifuge for 1 min at rt, at 
13,000 RPM. 
 
 4.1.13 Red-ET cloning technology 
 
Red-ET cloning technology relies on homologous recombination in vivo in E.coli. 
Homologous recombination occurs through homology regions, namely stretches of DNA 
shared by the two molecules that recombine. The mechanism and the practical steps of 
this technology is detailed in chapter 1, section 1.2.3.2.1. In this thesis, this technology 
was used to insert a NheI restriction site to the mutagenic oriented pFLEx-IRES-RFP-
GFP constructs which show different patterns of RNA pol II termination signals. Also, It 
was applied to create the Jarid1c gene targeting cassette.  
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4.1.13.1 PCR reaction  
 
PCR mix (50 μ l rxn) 
 DNA template x μl (1-5 ng)  
 dNTP  1 μl (10 mM) 
 F primer 1 μl (10 pmol)  
 R primer 1 μl (10 pmol) 
 5X Taq DNA polymerase buffer 5 μl 
Taq DNA polymerase 0.5 μl (2.5 unit) and X μl water to complete 50 μl. 
Denaturation was always carried out at 95
0
C. 30 cycles were performed and 
annealing temperature was optimized based on primer Tm for each reaction. The last 
cycle was always 10 min at 72
0
C. After checking 3 μl PCR product onto a gel, PCR 
products were pooled. It was not necessary to purify the product unless the template was 
replicative plasmid. For this kind of template, PCR products were digested with DpnI. 
For this digestion reaction, precipitate the 3 tubes x 50 μl PCR products, redissolve them 
in 80 μl, add 40 Unit DpnI and digest overnight at 37. Next day, through the ethanol 
precipitation clean the PCR product and resuspend this in 8μl sterile water. For 
transformation of PCR product, 3-4 μl PCR product is used (as a rule >0.2μg).  
 
4.1.13.2 Transformation of the Red-ET expression plasmid (pSC101-
BAD-gbaA) 
 
  Pick at least 8 colonies carrying the target plasmid DNA or BAC. Inoculate the single 
colony into the 2 ml LB with suitable selection agents, antibiotics, and incubate at 37
0
C 
with vigorous shaking (~1000 rpm) 12-16 hrs. 
  Next day, set-up eppendorf tubes containing 1 ml LB medium with suitable selection 
agents, antibiotics. Inoculate with 40 μl of overnight culture. Incubate 2 hours, at 370C  at 
1100 rpm.  
  After 2 hours incubation, make electro-competent cells. Centrifuge for 30 seconds at 
11,000 rpm at 2
0
C. Remove the supernatant by quickly tipping out twice and put on ice. 
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Add 1 ml ice-cold water, resuspend the pellet, centrifuge for 30 seconds at 11,000 rpm  at 
2
0
C. Repeat in a quick manner this washing, and resuspending steps twice. At last wash, 
keep 30 μl supernatant, and resuspend the pellet and put on ice. 
  1 μl (0.3 μg/μl) Red/ET recombination protein expression plasmid (pSC101-BAD-
gbaA) is added to this 30 μl bacteria suspension. Then, this is transferred to the chilled 
electroporation cuvvette. 
  Electroporate at 1350 volt, 10 μF, 600 Ohms.( Eppendorf electroporator 2510,1 mm 
electroporation cuvvette) 
  Resuspend the electroporated cells in 1 ml LB without selective agent, antibiotics. 
Incubate at 30
0
C, for 70 min at 1000 rpm. 
   After 70 min, plate 100 μl cells on LB agare plates containing the appropriate 
antibiotics for recipient bacteria and tetracycline (3μg/μl) for pSC101-BAD-gbaA). 
Protect the plates from the light, because tetracycline is negatively affected, and incubate 
overnight 30
0
C otherwise pSC101-BAD-gbaA will be lost at 37
0
C. For blasticidin 
reagent, the agar plates should be prepared with low salt LB, pH 8.5.  
 
4.1.13.3 Transformation of PCR product  
 
  Pick at least 8 clones from the pSC101-BAD-gbaA transformed recipient bacteria 
plates. Inoculate in 1 ml LB (or low-salt LB) with suitable antibiotics and tetracycline. 
Incubate at 30
0
C at 1000 rpm for overnight. 
  Next day, set-up eppendorf tubes containing 1 ml LB medium with suitable selection 
agents, antibiotics. Inoculate with 40 μl of overnight culture. Incubate 2 hrs, at 300C at 
1100 rpm.  
  Add  half of the tubes 20 μl L-arabinose (10%) giving a final concentration of 0.1-
0.2%. This will induce the expression of recombinase. Other half of tubes are used as 
control with no induction. All the tubes incubate at 37
0
C at 1100 rpm for 45 min. 
  After incubation, prepare the cells for electroporation. 
  Electroporate 3 μl PCR product at 1350 volt, 10 μF, 600 Ohms. (Eppendorf 
electroporator 2510,1 mm electroporation cuvvette) 
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  Resuspend the electroporated cells in 1 ml LB without selective agent, antibiotics. 
Incubate at 37
0
C, for 1 hour 10 min at 1100 rpm. Then plate 100 μl cells on LB agar 
plates containing the appropriate antibiotics carried by recipient bacteria and the PCR 
product. 
CRITICAL: Electrocompetent bacterial cells for the best recombination results should 
be used immediately. On the other hands, they can be kept at -80
0
C following the snap 
freeze in liquid nitrogen. 
 
4.1.14 Southern Blotting 
 
The basic idea behind southern blotting is to separate digested DNA 
electrophoretically then transfer the DNA pieces onto a positively charged nitrocellulose 
or nylon membrane. 
 
4.1.14.1 Gel electrophoresis and gel treatments for neutral transfer 
protocol 
 
  Following restriction digestion of genomic DNA(4.1.5 preparative reactions), 
overnight electrophoresis is preformed. DNA samples are separated on an 0.7 % agarose 
gel prepared with Tris/Borate EDTA (TBE) buffer by applying 40 volt for 24 hours. Next 
day, the gel is treated with an EtBr solution (10 μl  of 0.1μg/μl stock solution added to 1 
ml sterile water) to visualize the DNA samples in the gel with UV light and a photograph 
is taken. 
CRITICAL: Minimize the exposure of gel to UV light to avoid excessive nicking of 
DNA. 
The next step is now the 3 steps gel treatment for transfer the DNA to the membrane. 
  Depurination:  
Place the gel into the 0.125 M HCl, this should cover the gel completely. Agitate gently 
for 15 min, or till the loading dye is turned to yellow (around 10 min). Rinse the gel with 
sterile water. 
CRITICAL: Depurination is not required for DNA fragments < 10 kb. 
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  Denaturation:  
Place the gel into denaturation buffer; this should cover the gel completely. Agitate 
gently for 15 min, and then put fresh denaturation buffer and keep going with another 15 
min agitation. Rinse the gel with sterile water. 
  Neutralization:  
Place the gel into neutralization buffer; this should cover the gel completely. Agitate 
gently for 15 min, and then put fresh neutralization buffer and keep going with another 15 
min agitation. Rinse the gel with water. 
 
4.1.14.2 Blotting  
 
Put the gel in 20xSSC for 10 min with gentle shaking. Label nitrocellulose 
membrane, or nylone. Nylone membranes don’t need pre-wetting before use in blotting 
because they are hydrophilic. For large blots or for nitrocellulose membrane, first wet in 
water and then equilibrate in an SSC (the same gel treatment buffer). Arrange the suitable 
apparatus and allow DNA transfer to proceed overnight. Next day, take the membrane 
and mark slots with pencil on the membrane, rinse it with 6XSSC and vacuum dry for 2 
hours at 80
0
C.  
 
4.1.14.3 Radioactive DNA probe 
 
 Denature (100 ng DNA and sterile water to 11μl) DNA solution at 990C for 10 min 
 Put on ice then add 4 μl high prime (enzyme, primer,nucleotide mix,Roche) 
 Add 5 μl (50μC) alpha 32P dCTP, incubate for 1 hour at 370C 
 Centrifuge the G50 sephadex column for 2 min at 2500 g, at rt. 
  Apply the labelled DNA onto the column and centrifuge for 4 min at 2500 g, at rt. 
 Collect the flow through and determine the volume 
 Measure the radioactivity of 1 μl sample and calculate the total activity. 
 Use around 2x107 CpM for labelling the 10x10 cm DNA blotted membrane. 
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4.1.14.4 Hybridization in tubes 
 
 Pre-wet the membrane first with water and then 25mM NaHPO4.Roll and put into 
hybridization tube. 
 Add 8 ml hybridization buffer and pre-hybridize for 30 min at 62-650C. 
 Denature labelled DNA probe for 10 min at 990C after 30 min pre-hybridization step. 
 Remove the hybridization buffer, add 10 ml fresh hybridization buffer at suitable 
hybridization temperature with the membrane. Add labelled DNA probe and hybridize 
overnight. 
 Next day, pre-warm the buffer to 550C. Then rinse the membrane briefly. Then twice 
wash for 5 minutes at rt. Then, put wash buffer and incubate the membranes through 
rotating at 65
0
C for 15 min, and then remove the wash buffer. Add fresh wash buffer, and 
repeat the incubation through rotating rotating at 65
0
C for 15 min. Remove the buffer and 
check the membrane with the Geiger counter. 
 Remove the membrane, drain and wrap in saran wrap and expose to X-ray film 
(KODAK MR) for 72 hours in a film cassette at -80
0
C.  
 
4.2 RNA protocols 
 
4.2.1 RNA preparation from mammalian cells 
 
Although, some applications are tolerant of partially degraded RNA, extraction of 
intact and pure RNA which is not contaminated with proteins, DNA, organic solvents and 
other impurities is critical for downstream applications such as RT-PCR, Northern 
blotting, and RNAse protection assays. Therefore all items such as glasses and reagents 
should be RNAse free. Glass items can be treated with DEPC water for 24 hours then 
autoclaved. DEPC treated water should be prepared ( 0.1% solution, 1ml DEPC is added 
to the 1L water) and after 24 hrs they should also be autoclaved. In this PhD project, total 
RNA was isolated from mouse E14TG2a cells when they were confluent in a single well 
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of a 6-well-plate, and RNA was used for RT-PCR analysis of EGFP gene expression in 
the first series of FLEx-EGFP-neo random stables(E14TG2a cells). 
  Grow ES cells in 6-well-plate to confluence 
 
  Aspirate the media from 6 well plates containing confluent ES cells, wash once with 
3ml PBS, aspirate. 
 
  Add 800 μl PBS, and scrape by a soft movement with sterile scraper. Take the cells 
with a micropipette and put into an eppendorf tube. 
 
  Alternative to the scraping, put 300 μl trypsin, incubate 1-2 min at 370C, then add 
300 μl medium to inactivate the trypsin. Put into an eppendorf. 
 
  Centrifuge at 4000 x g, at rt for 4 min. 
 
  Wash with 1 ml PBS by spin at 4000 x g at 40C for 4 min. 
  Add 300μl Trizol reagent onto the cell pellet to lyse the cell, pass the lysate several 
times through a pipette to form homogeneous lysate. 
  Incubate the homogenized samples for 5 minutes at rt. 
  Add 30 μl of chloroform per 300 μl of Trizol and shake the eppendorfs vigorously by 
hand for 15 seconds and incubate them on ice for 5 min. 
  Centrifuge the samples for 15 min, at 40C, at 13,200 rpm. 
  Take upper clear aquaeous phase to a fresh eppendorf and add 150 to 200 μl 
isopropanol (volume should be 1:1) 
  Precipitate RNA via mixing and incubate them at rt for 10 min 
  Centrifuge for 15 min, at at 40C, at 13,200 rpm 
  Wash the pellet two times with 80% ethanol (one drop, quick spin, repeat twice) 
  Dry the pellet completely and dissolve in suitable amount DEPC water through 30 
min rt incubation. RNA samples should be stored at -80
0
C. 
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4.2.2 Reverse transcription of RNA (cDNA synthesis) 
 
Minimum and maximum template concentrations should be between 1ng-1μg for total 
RNA and 10 pg- 1μg for mRNA. 
 
  Set up the following components in an eppendorf tube 
1.2 μg total RNA(used in this PhD project) +2 μl(1.8 mg/ml) oligo(dT) + sterile water to 
13μl  
  Incubate 5 min at 700C, then put on ice for 5 min 
  Set up the following mixture and add per eppendorf 
dNTP  5 μl (10 mM) 
    RNAse out 1 μl  
         5X M-MLV reverse transcriptase buffer 5 μl 
                M-MLV reverse transcriptase 1 μl (more than 200 units)  
  Mix gently, spin down, and incubate 1 hr at 420C 
  Stop reaction at 700C for 15 min 
  Add 1 μl RNAse H and incubate at 370C for 20min 
For the PCR reaction, use 5 μl cDNA. 
 
4.3 Protein protocols 
 
4.3.1 Protein extraction from mammalian cells 
 
  Grow ES cells in 6-well-plate to confluence 
 
  Aspirate the media from 6 well plates containing confluent ES cells, wash once with 
3ml PBS, aspirate.         
 
  Add 800 μl chilled PBS, and scrape by a soft movement with sterile scraper. Take the 
cells with a micropipette and put into an eppendorf tube. 
  Centrifuge at 1000 rpm at 40C for 5 min, remove supernatant 
  On each cell pellet, add 50 μl protein extraction buffer  
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  Shock-freeze the cells in liquid nitrogen, and then put into the warm water(melt the 
cells). Additional two times repeat this freezing-melting steps 
  Then centrifuge at 13,200 rpm at 40C for 15 min, take the supernatant. 
  For the measurement of protein concentration using absorbance first 230 then 260nm, 
mix 5 μl protein extract and 0.1% SDS, use PMSF as a control. 
Concentration(μg/ml)= 100 x(183xOD 230-75.8xOD260) 
  
4.3.2 Polyacrylamide gel electrophoresis (PAGE) 
 
     5%Stacking gel (1 ml)                         10%Running gel (5 ml) 
     1M Tris pH 6.8 (0.13 ml)                           1.5M Tris pH 8.8 (1.25 ml) 
            30% AA (0.17 ml)                                           30% AA (1.7 ml) 
               10% SDS (0.01 ml)                                         10% SDS (0.05 ml) 
               10% APS (0.01 ml)                                         10% APS (0.05 ml) 
                TEMED (0.001 ml)                                         TEMED (0.002 ml) 
                 sterile water (0.68 ml)                                    sterile water (1.9 ml) 
 
  Prepare the stacking and running gel 
  Prepare 3μg protein extract mixed with coctail buffer(protein extraction buffer) to  
20 μl total volume. Add 1x protein loading buffer(4x stock). 
 
 Incubate at 700C for 5 min before loading 
 
Load the samples and run gel at 70 volt for 1 to 3 hrs depending on the size of protein 
should be detected.  
 
4.3.3 Western Blotting 
 
  Blot the proteins onto the Watmann membrane for 45 min, 15 V in a semi-dry blotter 
 
  Incubate the membrane in blocking buffer for 45 min at rt with gently agitating 
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  Add primary antibody (Roche GFP mouse antibody) 1:5000 into the blocking buffer 
(2μl Ab+10 ml blocking buffer), incubate overnight at 40C with gently agitating. 
  Next day, wash 3 times 20 min (total 1 hr) with PBS/0.1% Twin20 
  Then add secondary antibody (anti mouse antibody) 1:5000 into the blocking buffer, 
incubate 1 hr at rt with gently agitating. 
  Follow another 3 times washing step 
  For the enhanced chemiluminesence (ECL), mix 1:1 ECL solutions, luminal enhancer 
solution + stable peroxide buffer, put your membrane on it, cover and incubate for 5 min, 
drain on a piece of tissue, image the specific protein with LAS-3000 image system 
(FUJIFILM) 
 
4.4 Cell Culture Protocols 
 
4.4.1 Starting out with ES cells 
 
General steps for handling ES cells are growth, maintenance, passing, freezing, 
and thawing. They should be conducted in a careful way to keep the ES cells in a 
pluripotent state. The quality of the serum, with addition of the LIF, is critical for keeping 
the cells healthy and undifferentiated. 37
0
C and 5% CO2 are suitable incubation 
conditions.  Daily refeed is another critical process for keeping them healthy. As other 
molecular biology techniques, cell culture techniques require sterility and carefulness. 
 
4.4.1.1 Thawing the ES cells 
 
  Take the cell from freezers at, -80 for overnight, - 1500C for short-term storage (1-2 
months) or from liquid nitrogen tank for long-term storage. Quick thaw at 37
0
C water 
bath.  
  Transfer the cells to the 15 ml falcon tube, add 10 ml ES cell media, gently mix, 
make cell suspension and centrifuge at 1000rpm at rt for 5 min. 
  Aspirate off the supernatant, mix again cells, make cell suspension. 
 146
  Add 10 ml ES cell media, through pipetting make them single cell, and plate out them 
in a 10 cm cell culture dish. 1x10
6
 cell should be seeded per 10 cm plate.  
  Daily or every 2 days reefed them. When they reach 80 to 85 % confluence, passage 
them. Or freeze. 
 
4.4.1.2 Passage the ES cells 
 
ES cells in healthy conditions generally reach 80-85% confluence in 2 to 4 days. 
Cells must be fed when the media turn to orange. When the media turn yellow, don’t 
passage them. Before passaging the cells, feed them in the evening and the next morning 
before 3-4 hours. 
 
  Aspirate the medium, wash one time with certain amount of PBS. Add certain 
amount of trypsin and incubate at 37
0
C for certain time. Then same amount of ES cell 
media is added to inactivate trypsin.  
 
 
                       Amount of PBS        Amount of trypsin      Incubation  
10 cm plate                10 ml                             1ml                          5 min 
6-well-plate                 3 ml                             500μl                        5 min 
24-well-plate               1 ml                             200 μl                      3-4 min 
48-well-plate              500 μl                           100 μl                      2-3 min 
96-well-plate              100 μl                            40 μl                        2 min 
  Again with pipetting, make them single cell. This is very critical step. Determine the 
cell numbers. Split them 1:3,1:4 or 1:10 and plate them into the suitable dishes. 
 
4.4.1.3 Freezing the ES cells 
Check the cells under the microscope for 80-85 % confluence. Refeed 3-4 hrs 
before passaging. Trypsinize cells from the 10 cm dish and add ES cell media to 
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inactivate as described. Put on ice, add same volume (1:1), 2 ml freezing media, then split 
into 1 ml freezing vials. Each vial should contain 3x10
6
 cell. For short-term storage put at 
-80 (overnight) or -150 (1-2 months). For long term storage, liquid nitrogen tanks are 
preferable. 
  
 4.4.2 Electroporation into ES cells 
 
 
  Cell preparation is the critical step. 80% confluent ES cells should be split 1:2 one 
day before the electroporation. During the electroporation day, 3-4 hrs prior they should 
be reefeded. 
  Trypsinize the cells and resuspend in media as described. Count 10 μl sample. 
  Pellet the cells, and resuspend in PBS. (1x107 cells/900 μl PBS) 
  40μg linearized DNA(1μg/1μl TBE or PBS or water) is put onto the cell suspension, 
then transfer them to the gene pulser cuvvette (0.4 cm electrode gap) 
  Incubate 5 min on ice 
  Set electroporator 240 V, 500μF, and pulse the cells (time constant should read 
between 5.6-7.0). 
  Leave the cuvvette on ice for 5 min. Then plate the 1x106 cells in a 10 cm dish. 
  After 24 hrs, with a suitable antibiotic, start colony selection. In this project, the cells 
after 24 hours were reefed by G418 (0.2μg/ml ) and BSD (0.5μg/ml) for 3 days, then 
every 2 days the media was changed until the colonies were visible. For G418 around 
10.day the colonies were ready to collect, for BSD after 14. day, the colonies were 
picked.  
 
4.4.2.1 Picking the ES cells and transferring them to the 96 wells 
 
The best time for picking the cell colonies is around 10 to 11 days, although they 
could be picked as late as 8 days, and colonies can be recovered 18 to 21 days after 
electroporation. 
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  When the time is suitable for picking the colonies, first remove the media and put 
around 4to 5 ml PBS on the 10 cm dishes.  Under the microscope, using a 20μl 
micropipette, pick colonies into the 96 well plate.  
 
  Through several pipetting up and down, make the colonies single cells. Then add 
100μl ES cell medium containing suitable a selective reagent, antibiotic. 
CRITICAL: The cells should be examined daily for their confluence. Generally in 2 days, 
the colonies reached certain confluence in 96 well plates and should be transfered into the 
48 well plates. Another 2 days is required before transferring them to 24 well plates, and 
then in 2 days later transfer  to 6 well plates through trypsinization and inactivation of the 
trypsin as described. 
 
4.4.3 Transient transfection of DNA via lipid vesicles (Lipofectamine) 
 
In this PhD project, this method was used to introduce FLEx-IRES-RFP 
constructs into mouse E14TG2a cells to quickly test the constructs and to transfect the  
pCAGGs-Cre-puro plasmid into the mutagenic oriented FLEx-IRES-RFP (with different 
version of pausing signals) random stables (mouse E14TG2acells). This protocol used in 
this project grew the cells in 6 well plates. 
 
  Each 6 well plate contains 3x105 cells/3ml medium. Mix 1μg DNA and 50μl DMEM 
(contains no serum) gently. Prepare lipofectamine, first mix the stock gently, and then put 
3μl lipofectamine from the stock into the 50 μl DMEM (DNA:lipofectamine: 1:3) 
Incubate them at rt for 5 min.  
 
  Following the incubation, mix 50 μl DMEM containing DNA and 50 μl DMEM 
containing lipofectamine. Incubate them at rt for 20 min. 
 
  Then add 100 μl DNA and lipofectamine mixture to the 6 well, on top of the cells. 
Mix gently by rocking the plate back and forth. 
  
  Incubate the cells at 37 5% CO2 for 24 to 48 hours until they are ready to assay 
transgene expression. It is not necessary to change the medium. 
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5. MATERIALS 
 
5.1 Chemicals and solutions 
 
Acetic acid, glacial MERCK 
AA(Acrylamide/bisacrylamide) SEVERN BIOTECH LTD  
Agarose INVITROGEN,ROTH  
Ampicilline SIGMA  
APS SIGMA 
Bacto-Agar BD 
Blasticidin S HCl 
Blasticidin S 
INVITROGEN (prokaryotic system) 
INVIVOGEN    (mammaliansystem) 
Bromophenolblue MERCK 
BSA SIGMA 
Chloramphenicol SIGMA 
Chloroform MERCK 
DMSO 
ECL solution 
SIGMA 
AMERSHAM 
EDTA disodium salt SIGMA 
Ethidiumbromide 
Ethanol 
SIGMA 
MERCK 
G418 INVITROGEN 
Glycerol MERCK 
Glycogen ROCHE 
HCl MERCK 
IPGT SIGMA 
Isopropanol MERCK 
Kanamycin sulfate SIGMA 
KCl MERCK 
L-Arabinose SIGMA 
-Mercaptoethanol SIGMA 
MgCl2 SIGMA 
Milkpowder HAIRLER 
Na2HPO4 MERCK 
Na-citrate MERCK 
NaCl MERCK 
NaOAc MERCK 
NaOH MERCK 
Phenol/Chloroform/Isoamylalcohol 
Puromycine 
SDS 
SIGMA 
SIGMA 
BIORAD 
TEMED 
Tetracycline 
SIGMA 
SIGMA 
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Trizma base MERCK 
Trizol SIGMA 
Tween 20 SIGMA 
X-gal BIOMOL 
 
5.2 Media and Supplements 
 
DMEM with Glutamax INVITROGEN 
FCS INVITROGEN 
L-Glutamine INVITROGEN 
LIF recombinant STEWART LAB 
Non essential aminoacids BIOCHROME 
Penicillin/Streptomycine INVITROGEN 
Sodium Pyruvate INVITROGEN 
Trypsin/EDTA 1x INVITROGEN 
 
5.3 Other reagents 
 
5.3.1 Enzymes, markers and nucleotides and other reagents 
 
All restriction enzymes NEB 
Asp718 ROCHE 
Deoxyribonuclease I INVITROGEN 
Ribonuclease A SIGMA 
Ribonuclease H INVITROGEN 
Proteinase K 
Proteinase inhibitor coctail 
MERCK 
SIGMA 
T4 DNA ligase NEB 
Klenow large fragment NEB 
dNTP mix SIGMA 
1 kb DNA ladder INVITROGEN,NEB 
1 kb plus DNA ladder INVITROGEN 
Prestained protein marker,broad range NEB 
alpha 
32
P dCTP AMERSHAM 
  
 
 
 
 
 
 151
5.3.2 Kits 
 
Plasmid maxi preparation kit QIAGEN 
Qiaquick PCR purification kit QIAGEN 
Qiaquick gel extraction kit QIAGEN 
BACMAX DNA purification kit EPICENTRE 
Triplemaster PCR system EPPENDORF 
High prime 
(random primed DNA labelling kit) 
ROCHE 
Lipofectamine 2000 INVITROGEN 
 
5.3.3 Antibodies 
 
Anti-beta actin monoclonal antibody                                  SIGMA 
Mouse anti-GFP monoclonal antibody (unconjugated)      ROCHE  
Anti-mouse Ig G conjugated horsedish preoxidase (goat)  ROCHE 
 
5.4 Instruments 
 
Balancer (TE3102S) SARTORIUS 
Cell culture centrifuge (Multifuge3 S-R) 
Cell counter CASY 
HERAEUS 
SCHARFE SYSTEMS 
Cell culture hood HOLTEN 
Cell culture incubator HERAEUS 
Cell culture incubator (Heracell 150) HERAEUS 
Cell culture microscope (CK40)                     OLYMPUS 
Cell culture fluorescent 
microscope(CKX41) 
OLYMPUS 
Cell culture rotor(6445) HERAEUS 
Cell culture water bath GFL 
Centrifuge table top(5415D) 
Centrifuges 
Rotors  JLA16.250,JS13.1                              
EPPENDORF 
BECKMAN COULTER(Avanti J25) 
BECKMAN COULTER 
Digital camera (C304OZoom) OLYMPUS 
ECL hyperfilm AMERSHAM 
Electrophoresis power supply EMBL PS143 
Electroporator bacterial cells(2510) 
Electroporation cuvvette (1 mm) 
EPPENDORF 
EPPENDORF 
Electroporator ES cells (gene pulser X) 
Electroporation cuvvette (4 mm) 
BIORAD 
BIORAD 
Geiger counter (LB122) BERTHOLD 
Gel documentation system BIORAD 
Glassware SCHUTT DURAN 
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Hybridization oven 
Incubators (bacterial system) 
LAS3000 Image system 
Nanodrop ND1000(spectrophotometer) 
BACHOFER 
INFORS AG 
FUJIFILM 
PeqLab Biotechnologie GMBH 
PCR machine (Robocycler) STRATAGENE 
PCR machine (Epgradient S) EPPENDORF 
Semi-dry transfer blotter BIORAD 
Scintillation counter BECKMAN COULTER 
Spectrophotometer 2100 AMERSHAM 
Spectrophotometer quartz cuvvette SIGMA 
Thermoshaker (1.5/2 ml) 
UV stratalinker 2100 
EPPENDORF 
STRATAGENE 
Vacuum oven                                                    KENDRO 
 
5.5 Disposables 
 
Bacteria plates GREINER 
Cell culture freezing vials NUNC 
Cell culture pipettes (2,5,10,25 ml) COSTAR 
Cell scraper (23 cm) NUNC 
Centrifuge tubes (1.5 and 2 ml) EPPENDORFS 
Centrifuge tubes (12, 15 and 50 ml) FALCON 
Combitips EPPENDORFS 
Filters (0.22μm) MILLIPORE 
Filters (0.45μm) MILLIPORE 
Filters steritop (0.45μm, 500 ml) MILLIPORE 
Gloves SAENGER 
Inoculation needles NUNC 
Nitrocellulose membrane for protein 
transfer ( protran) 
SCHLEICHER+SCHULER 
Positively charged nylone membrane for 
DNA blotting 
AMERSHAM 
PCR tubes (0.2 ml chain) SARSTEDT 
Pipette tips(P2,P10,P100,P1000) SARSTEDT and NERBE PLUS 
Spectrophotometer plastic cuvvettes SARSTEDT 
Syringes BECTON/DICKINSON 
Tissue culture plates (96,24,6 well) NUNC 
Tissue culture plates (48 well, 10 cm)  FALCON 
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5.6 Buffer Systems 
 
5.6.1 Plasmid DNA purification system 
 
P1 buffer                     P2 buffer            P3 buffer                 
50 mM        Tris-HCl         200 mM NaOH       3 M potassium acetate 
10 mM        EDTA             1% SDS  
100 μg/ml   RNAse A  
 
QBT buffer                         QC buffer                   QF buffer 
750 mM NaCl                               1 M         NaCl                   1.25 M      NaCl    
50 mM  MOPS                             50 mM    MOPS                 50 mM      Tris, pH 8.5 
15%      isopropanol                      15%        isopropanol         15%           isopropanol 
0.15%   tritonX-100 
 
TE buffer 
10 mM  Tris 
1mM    EDTA 
 
5.6.2 Agarose gel electrophoresis system 
 
10X loading buffer        TBE (5X)                                                          
25%       Ficoll                        54 g  Trizma base 
100 mM EDTA                      27.5 g Boric acid 
Bromophenol blue                  20 ml 0.5M EDTA, pH 8 add sterile water to 1 l 
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5.6.3 Genomic DNA purification system 
 
Lysis buffer                           
50 mM      Tris-HCl, pH 8 
100 mM    EDTA 
100 mM    NaCl 
1%            SDS 
0.5 mg/ml Proteinase K( dissolve 100 mg proteinase K in 10 ml sterile water, aliquot and 
store at -20
0
C). 
 
5.6.4 Southern blotting system 
 
Depurination solution     Denaturation solution    Neutralization solution 
37% HCl      10 ml NaCl                87 g NaCl               87 g 
sterile water to 1l NaOH pellets   20 g Tris                121 g 
 sterile water to  1 l 37% HCl       50 ml 
sterile water   to 1 l 
20 X SSC 
NaCl                                      175 g 
tri-Sodium citrate dihydrate    88 g 
sterile water  to                        1l 
 
1M Hybridization stock                       1X Hybridization buffer 
Na2HPO4        89 g                                          250 mM Na2HPO4    50 ml 1M stock 
Adjust to pH 7.2 with H3PO4                           7% SDS                     35 ml 20% stock 
                                                                           1% BSA                     1 g 
                                                                           1mM EDTA               100 μl 0.5 M stock 
                                                                           15 ml sterile water 
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Wash buffer 
20mM Na2HPO4, pH 7.2             40 ml   1M stock 
1%  SDS                                       50 ml  20% stock 
1mM EDTA                                   2 ml 0.5 M stock            
sterile water to                                1 l 
 
20% SDS 
200 g SDS+ 1 l water dissolve (heat) 
 
5.6.5 Western blotting system 
 
Protein extraction buffer (coctail) 
250 mM Tris, pH 7.8                 1 ml 
1% protease inhibitors               10 μl 
100 mM PMSF                         10 μl  
100 mM DTT                            10 μl 
  
Sample loading buffer 
0.5 M          Tris/HCl, pH 6.8                
2% (v/v)     -mercaptoethanol 
20% (v/v)   glycerol 
bromophenol blue in distilled water 
 
Transfer buffer                                                             Blocking buffer 
39 mM glycine                2.9 g                                        5% milk powder 
48 mM Trizma base        5.8 g                                        0.1% Tween 20 in PBS 
0.037% SDS                   1850 μl 20% SDS 
20% methanol                 200 ml 
water to                            1 l       
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5.7 Cell Culture Systems 
 
5.7.1 Bacterial culture system 
 
 For bacteria, small quantities of are usually grown on solid support that contains 
nutrients embedded on it called bacterial agar, and  and large scale  quantities of are 
grown in liquid media containing nutrients.  
 
LB (Luria Bertani medium, pH 7.4)                               LB agar 
1% bacto tryptone            10 g                                                             15g  bacto agar 
0.5 % bacto yeast              5 g                                                                1l    LB,pH 7.4 
1% NaCl                          10 g                                                                      boil 
water to                               1 l 
 
Media for antibiotic selection 
 
Chloramphenicol Stock (30mg/ml in ethanol) 15 μg/ml for BAC and low copy plasmids,  
50 μg/ml for high copy plasmids 
Ampicillin Stock (100mg/ml in 50%  
ethanol) 
50 μg/ml for BAC and low copy plasmids, 
100 μg/ml for high copy plasmids 
Kanamycin Stock (30mg/ml in sterile 
distilled water) 
15 μg/ml for BAC and low copy plasmids,  
50 μg/ml for high copy plasmids 
Blasticidin S HCl Stock (10mg/ml in sterile 
distilled water) 
4 μg/ml for BAC and low copy plasmids,  
5 μg/ml for high copy plasmids 
Tetracycline Stock (10mg/ml in 75% 
ethanol) 
3 μg/ml for BAC and low copy plasmids,  
5 μg/ml for high copy plasmids 
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5.7.2 Mammalian cell culture system 
 
Basic media for mouse embryonic stem cells            2x Freezing media 
 
Fetal calf serum (filtered through 0.22μm 
pore filter) 
 75 ml                  50% Fetal calf serum        
100 U: μl/ml  penicillin/streptomycin   5 ml                   20% DMSO 
L-glutamine   5 ml                   in DMEM glutamax 
-Mercaptoethanol  
(7μl in 10 ml PBS) 
  5 μ l 
Na pyruvate   5 ml 
Non-essential aminoacids   5 ml 
LIF (leukaemia inhibitory factor) 
10
6
 or 10
7 
U 
  1 ml 
DMEM glutamax 400 ml 
  
 
Media for antibiotic selection 
 
  G418 Stock 
(50mg/ml in 
HEPES) 
0.20 
mg/ml 
Blasticidin Stock 
(5mg/ml in 
dd water) 
5μg/ml 
Puromycin Stock 
(1mg/ml in 
dd water) 
1μg/ml 
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7. ABBREVIATIONS 
 
 
APLP Amyloid precursor like protein 
BAC bacterial artificial chromosome 
BSD blasticidin 
bp base pairs 
CMV Cytomegalovirus 
ColA1 Collagen alpha 1 
CoTC co-transcriptional cleavage 
C terminus carboxy terminus 
DNA deoxyribonucleicacid 
EDTA ethylene diamine tetra acetic acid 
GLT1 Glutamate transporter 
hprt hypoxanthine-guanine phosphoribosyl 
transferase  
kb kilobase 
kDA kilodalton 
MRFP Myogenic regulatory factor 
mRNA messenger ribonucleic acid 
Myf5 Myogenic factor 5 
ND Norrie disease 
neo neomycine 
o/n overnight 
pA polyadenylation 
PCR polymerase chain reaction 
PGK phosphoglycerate kinase 
RNA ribonucleic acid 
RT room temperature 
sA splicing acceptor 
wt wild-type 
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